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1 Introduction  
1.1 The kidney, structure and primary function 
The kidneys of mammals are paired organs located in the lower abdominal cavity 
behind stomach and intestines on the left and right side of the spine. The huge number 
of different cell types present in the kidney gives an impression of the different 
physiological functions fulfilled by these organs.  
The central function of the kidneys is the excretion of urinary metabolic waste products 
and keeping the acid/base and water homeostasis in the body. Closely connected to 
this is the control of systemic blood pressure and the renin-angiotensin-aldosterone 
system (RAAS) (Figure 1). 
Other important functions are the production and release of hormones such as 
erythropoietin (EPO) for the formation of new red blood cells and calcitriol, the active 
metabolite of vitamin D, a central hormone for the bone metabolism1,2. 
Contained in a capsule of connective tissue, the mammalian kidney can be divided into 
three major zones: the cortex, the outer and the inner medulla. The most prominent 
functional subunit of the kidney is the nephron, including the glomerulus as the site of 
primary urine filtration and the following tubular system for urinary concentration. The 
human kidney contains about 1 million glomeruli, the murine kidney averages about 
12.000 to 16.000 glomeruli.3  
The primary urine is filtered in the capillary slings of the glomerulus by a system of 
three cooperative membranes, the fenestrated capillary endothelium, the basal 
membrane and the slit membrane between the long foot processes of the podocytes. 
Each glomerulus is surrounded by a bowman capsule and embedded in between other 
glomeruli, capillaries, interstitial cells and the proximal tubules in the kidney cortex. 
From the glomerulus, the primary urine is transported along the proximal tubule 
through the loop of Henle to the distal tubule and into the collecting duct (CD). During 
the passage of the urine through the different parts of the tubular system, important 
electrolytes such as sodium, potassium and glucose as well as the majority of the 
filtered water are reclaimed by an osmotic countercurrent system between the tubules 
and the adjacent blood vessels.  
The function of the macula densa cells is the sensing of luminal ion concentrations, 
especially chloride, and the appropriate adjustment of glomerular filtration and 
electrolyte reuptake4,5. These cells are a specialized subtype of the cortical thick 
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ascending loop of Henle (cTAL) and are located in close proximity to the renin 
producing cells at the vascular pole of the glomerulus. Together with the renin 
producing cells and extra-glomerular mesangial cells, they form the juxtaglomerular 
apparatus (JGA)6.  
 
Depending on the luminal chloride concentration, the cells of the macula densa control 
the synthesis and release of renin from the adjacent cells4,7. Renin, an aspartyl 
protease the rate limiting enzyme of the RAAS converts angiotensinogen, produced in 
the liver, to angiotensin I by cleaving a decapeptide of the N-terminal end8–10 (Figure 
1). Angiotensin I is then further processed by the angiotensin-converting-enzyme 
(ACE) to angiotensin II (ANG II) which can bind to two different angiotensin receptors 
(AT1 or AT2) in humans. After binding to its receptors, ANG II exerts a broad spectrum 
of effects such as vasoconstriction leading to a reduced renal blood flow, release of 
aldosterone for a heightened reabsorption of sodium in the proximal tubule and 
vasopressin release leading to water retention. All these effects are aimed toward 
maintaining blood pressure and water homeostasis under varying conditions such as 
changed dietary salt intake or an acute volume challenge7.  
Beside tubular cells, the most numerous cell type in the kidney are interstitial pericytes 
and fibroblast-like cells. These cells are located between the tubules and small vessels 
across all kidney zones and uphold the kidney structure3,11.  
Figure 1: Schematic overview of the RAAS and its most important physiological effectors; after generation of ANGI 
by renin the ACE converts it to ANGII that exerts the physiological effects through binding to AT1 or AT2 receptors 
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By the classical definition, only cells in direct contact to blood vessels are labeled as 
pericytes1,12,13. Other, non-classical pericytes, located in the interstitial space of the 
kidney, share many characteristics and cellular markers with classical pericytes and 
are called interstitial fibroblast-like cells. These cells show the same morphology as 
pericytes with elongated cell processes and close contact to tubules, but are not 
inflammatory or endothelial cells (Figure 2). Functionally these cells produce collagen, 
fibronectin and include the population of native EPO producing cells in the kidney1,14. 
Due to the similarities between classical pericytes and interstitial fibroblast-like cells a 
clear distinction is difficult. Additionally, the above-mentioned overlap in markers, such 
as the platelet derived growth factor receptor β (PDGFR-β) in the whole kidney and 
ecto-5'-nucleotidase (CD73) in the cortex gives no clear identifier1. This overlap is 
probably caused by their common origin from forkhead box D1 positive (FoxD1+) 
stromal progenitor cells (Figure 3)3,15,16. Due to the close relation of these cell types, 
the terms pericytes and interstitial cells are used synonymously in this work.   
Figure 2: Stylized view of interstitial fibroblast-like cells in the kidney; interstitial cells are located between tubules 
(t) and vessels (v) in the interstitial space across the kidney, their long cellular processes are wrapped around  
tubules, vessels and also other interstitial cells; interstitial cells in direct contact with blood vessels are classically 
viewed as pericytes 
  11 
 
Other cells from the compartment of stromal progenitors are the mesangial cells, renin 
producing and vascular smooth muscle cells11,17.  
 
1.2 Cyclooxygenase 
1.2.1 Structure and Subtypes, Prostaglandin production and regulation 
The first enzyme described to catalyze the reaction of arachidonic acid (AA) to 
prostaglandin G and H (PG), was discovered in 1971, called prostaglandin-
endoperoxide synthase (PTGS)18 and cloned in 198819. The later discovery of a 
second isoform of this enzyme led to the distinction into Cyclooxygenase (Cox) 1 and 
220,21. More recently a third isoform of Cox, Cox-3, has been reported in the central 
nervous system and heart of mice. This Cox-3 is a splicing variant of Cox-119,22. 
Splicing variants of Cox-2 have also been reported, but none showed an enzymatic 
activity19.  
Cox-1 and Cox-2 share about 66% of their amino acid sequence, but are located on 
different chromosomes19,23–27. The two enzymes differ in a number of important key 
factors. In Cox-2 the catalytic center is larger than in Cox-1, but the speed for the 
reaction of arachidonic acid to prostaglandin H2 (PGH2) is similar19,28. The speed of 
Cox-3 on the other hand is markedly lower19,22. Intracellular Cox-1 and Cox-2 both can 
be found in the endoplasmic reticulum and on the nuclear envelope. But two isoforms 
Figure 3: Cells deriving from the FoxD1+ stromal progenitor compartment of the kidney include interstitial pericytes, 
mesangial cells, renin producing cells and vascular smooth muscle cells; cells of HoxB7+ decent differentiate into 
the collecting ducts while cells of the Six2+ mesenchyme become the tubular system; figure modified from Gerl 
2018 
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differ in the source of AA used in the catalyzed reaction, which for Cox-1 is mostly 
exogenous while Cox-2 uses both endo- and exogenous sources of AA. The intrinsic 
intracellular mobilization of AA from phospholipids of the nuclear membrane is most 
relevant for the function of Cox-2 and can be affected by a number of different 
phospholipases (PL) for example the cytosolic or secreted form of PLA2 (cPLA2, 
sPLA2)19,28. 
 
Cox catalyzes the reaction of AA to PGH2 in two sequential reactions. In the initial step 
AA is cyclized by Cox-1 or Cox-2 through the formation of a 15-hydroperoxy group, 
resulting in PGG2. This cyclizing step gave the Cyclooxygenase enzymes their name. 
In the following step, performed by the same enzyme, PGG2 is reduced at the 
hydroperoxy group to PGH219. Once arachidonic acid has been transformed to 
prostaglandin H2, specialized and locally restricted synthases catalyze the reactions to 
the biologically active compounds such as PGE2, PGI2, PGF2α and TXA2 (Figure 4)29. 
In the kidney, the most abundant prostaglandin is PGE2. It is formed mostly by the 
microsomal (also called membrane associated) prostaglandin E synthase (mPGES1 
or 2)19,30,31. Other PGES have been described for the formation of PGE2 but are not 
predominant in the kidney.  
Figure 4: Pathway of prostaglandin synthesis from AA to the different biologically active prostaglandins; AA is 
converted to prostaglandin PGH2 by either Cox-1 or Cox-2, depending on cell and tissue type; from PGH2 
specialized synthases are responsible for the formation of the effector PGs; figure modified after Hao et. al 2008 
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Through the multidrug resistance protein 4 (MRP4) PGE2 is transported out of the cells 
and can affect the surrounding tissue32. Receptors for prostaglandins formed by Cox-
1 and Cox-2 are G-protein coupled E-prostanoid receptors (EP) of different subtypes, 
locations and functions31,33–35.  
A further difference between the two Cox genes is their translational regulation, so that 
the production of PGs is in part controlled through the degree of Cox gene expression. 
Cox-1 has been labeled as a “housekeeping”-gene with a stable constitutive 
expression in many tissues, it lacks inducible promotor regions in the 5´- region of the 
gene19,28. For Cox-2 a number of distinct promotor regions in the 5´ sequence have 
been identified4,28,36,37 (Figure 5).   
 
Among the transcriptional factors enhancing the Cox-2 gene expression many growth 
factors such as NF and PDGF as well as inflammatory stimulants such as IL-6 and 
NFκB can be found4,37–40. The numerous promoters of the Cox-2 gene also explain its 
designation as “the inducible” Cox isoform. In the 3´-untranslated region of the Cox-2 
gene two different binding sites influencing the stability of Cox-2 mRNA could be 
sequenced4,41. A region with a 22 times repeat of the mRNA destabilizing AUUUA 
motive was found, but a binding site for IL-1β stabilizing the mRNA could also be 
identified42. It has been postulated that the AUUUA rich regions are responsible for the 
Cox-2 suppressing effects exerted by glucocorticoids, as these regions are missing in 
the Cox-1 gene41. 
 
 
Figure 5: Stylized overview of the different promotor sites associated with the Cox-2 gene; in the 5´-region various 
inflammatory as well as growth factors are able to bind and then induce transcription of the Cox-2 gene; among 
these are Nuclear factor-kappa-B (NFκB), transcription factor Sp1(SP1), myocyte enhancer factor-2 (MEF2), 
nuclear factor (NF), interleukin 6 (IL-6), a cAMP-responsive element (CRE) and a TATA motive; in the 3´-
untranslated region of the Cox-2 gene, regulator regions for the stability of the mRNA could be identified; figure 
modified from Harris et. al 2001 
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1.2.2 Localization of Cox in the kidney  
In the human and murine kidney, the two Cox isoforms and their respective 
prostaglandin receptors have been located in diverse compartments4,23,29,43,44. 
Cox-1 is thought to be expressed in the loop of Henle, smooth muscle cells, collecting 
ducts, endothelial cells and interstitial cells23,28. The expression of Cox-2 is more 
contested. Controversial locations for the expression of Cox-2 have been published 
over the years for humans and different laboratory animals43–45. The most commonly 
postulated expression sites for Cox-2 in mammals are the cells of the macula densa in 
the renal cortex and medullary interstitial cells43,44,46,47. But the low expression of Cox-
2 in mice and humans, when compared to other laboratory animals such as rats, has 
made the investigation of this enzyme difficult43. 
As mentioned above the cells of the macula densa are specialized cells of the cTAL 
and part of the JGA. Due to the involvement of the macula densa cells in the regulation 
of renin release, this Cox-2 expression site has been studied extensively 4,5,7,23,28,43. 
While some functions for the interstitial medullary Cox-2 expression have been 
postulated (see 1.2.3) the nature of these cells and their origin has not been 
investigated in detail48.  
 
1.2.3 Function and regulation of Cyclooxygenase-2 in the kidney 
In the kidneys of mice PGE2 is the most abundant prostaglandin in the cortex and 
medulla, but PGI2 and PGF2α can also be detected in substantial concentrations30,49. 
In principal Cox-1 and Cox-2 are able to produce these prostaglandins. A number of 
physiological functions have been postulated for these prostaglandins based on 
different models. More functions of Cox in the kidney became apparent with the 
widespread use of Cox inhibitors to treat pain and inflammation. 
The cells of the macula densa sense the ion concentration in the lumen of the cTAL 
through the transport rate of the Na+-K+-2Cl- (NKCC2) cotransporter4,6,10. It has been 
postulated that a lower luminal salt concentration or the pharmacological inhibition of 
NKCC2 leads to an activation of intracellular kinases such as p38 mitogen-activated 
protein kinase (p38), mitogen-activated protein MAP kinases ERK1 and 2 which in turn 
activate Cox-24,6. This same pathway also induces the microsomal prostaglandin E 
synthase (mPGES)50 in the macula densa cells that processes PGH2 into PGE2, which 
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then effects the release of renin. But the degree to which renin release is dependent 
on Cox-2 is still unclear10.  
In the renal medulla, the postulated functions and mechanisms for Cox-2 are more 
diffuse. PGE2 has been repeatedly linked to cell survival under hypertonic stress such 
as during dehydration24,51 and to the salt handling ability of the kidney30,52–54. The 
cellular expression site and Cox-isoform involved in these functions and the underlying 
mechanism have not yet been defined. 
Besides dehydration, other conditions have been reported to induce medullary PGE2 
formation. For example an increased dietary salt intake leads to increased PGE2 in the 
medulla48,53. Additionally, PGE2 has also been reported to play a protective role in 
states of renal tissue hypoxia and during times of high medullary oxygen 
consumption55–57.  
 
1.2.4 Pharmacological inhibition of Cyclooxygenase  
Blocking cyclooxygenase activity has been one of the first ways of pain 
management19,58. But the inhibition of both isoforms, Cox-1 and Cox-2, with non 
steroidal anti-inflammatory drugs (NSAIDs) is associated with a predisposition for 
hypertension, gastro-intestinal lesions and increased renal and cardiovascular 
risks31,59–67. Furthermore the application of Cox-inhibitors during pregnancy can cause 
severe renal developmental defects68,69. These side effects were long attributed to the 
unspecific block of Cox-1, the “housekeeper” isoform, by NSAIDs.  
The larger binding pocket for AA in the Cox-2 enzyme made it possible to design drug 
molecules inhibiting only Cox-2 activity28. Unfortunately, the introduction of these Cox-
2 specific inhibitors did not eliminate all side effects. On the contrary, as Cox-2 
selective inhibitors gained widespread use as chronic pain mediators with less gastro-
intestinal side effects, it became clear that these drugs had severe side effects unique 
to their class44,68,70.  
Cox-2 selective inhibitors are associated with an increased risk of hypertension71 and 
decreasing the efficiency of antihypertensive drugs44,62,72,73.  A link between dietary salt 
intake, Cox-2 selective inhibitors and blood pressure dysregulation in otherwise 
normotensive patients has also been published10,48,54,59,74. In some patients treated 
with Cox-2 selective inhibitors, incident of papillary necrosis, water and sodium 
retention with edema and tubulo-interstitial nephropathy were reported31,44,45,66,67,70.  
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These effects showed that Cox-2, which had been labeled as the inflammatory induced 
isoform at its discovery, must also have important basal functions besides inflammation 
and pain. But the detailed origin and mechanism for the heightened incidence of 
cardiovascular events, renal injury and the salt sensitive hypertension have not yet 
been described completely44,70,75. It is also not clear yet where inhibition of Cox-2 
expression is causative for these side effects.  
 
1.2.5 Models for the functional investigation of Cox-2 in the kidney 
To date most of the functional data for Cox-2 in the kidney has been gathered either in 
rat or dog models43,44,46,54,74,76–79, in cultivated cells24,53,80 or global deletion models for 
mice49,61,81,82.  
An inherent problem with isolated cells are the phenotypic and genetic shifts that can 
occur by taking the cells out of their in-vivo environment. It is to be expected that the 
generation of a stable cell line from primary cells also leads to a change in the 
expression of a number of genes83. The Cox-2 expressing cells in the medulla are just 
described as interstitial cells in the literature4,28,46,53. It is conceivable that the function 
of these cells is influenced by their close contact to other cells, vessels and tubules 
around them84. This cell-cell interaction is lost in a cultured environment. Further 
complicating the investigation of Cox-2 besides the low basal expression in mice is the 
lack of a reliable antibody to locate Cox-2 in different tissues of mice or other laboratory 
animals. 
The difficulty with the use of rats or other species for the investigation of Cox-2 is the 
lack of information about the comparability of Cox-2 expression between mice, rats 
and humans concerning the expression pattern and strength as well as the 
regulation43–45. Furthermore, the lack of genetically modified rats only allows for either 
a systemic inhibition of Cox-2 or very complicated experimental approaches for the 
medullary infusion of pharmacological compounds46.  
Even in mice, only global knock-out models for the key components of the 
prostaglandin pathway were available until recently. Dinchuk et.al81 generated a 
mouse model with a global deletion of Cox-2 in all cells (Cox-2-/- mice). This model 
provided insights into the function of Cox-2 but the global deletion complicates the 
distinction between the different expression sites for Cox-261,81,85,86. However, these 
mice showed good parallels to human pathologies after NSAID application. Cox-2-/- 
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mice presented with problems in postnatal kidney development as seen in human 
fetuses with NSAID application during pregnancy, culminating in a severe kidney 
phenotype44,61.  
This phenotype consists of a reduced number of sclerotic glomeruli with a subcapsular 
location, interstitial fibrosis and papillary atrophy (Figure 23)61,81. The subcapsular 
glomeruli have a low renin expression in their JGA region and are most likely not 
functional87. Another study showed that the severity of this phenotype was dependent 
on the genetic background of the mice used61.  Cox-1 knock-out mice show no renal 
phenotype61.  
Despite the novel insights provided by this model it is not very suitable for the separate 
investigation of different Cox-2 functions, because the deletion affects all cells. 
Furthermore, the severe renal phenotype that develops during nephrogenesis and 
leads to the malformation in the kidneys of Cox-2-/- mice, prohibits a direct transfer of 
the findings in this mouse model to normally developed murine kidneys and humans.  
Ishikawa et. al established a new mouse model with floxed Cox-2 alleles, allowing for 
the first time the targeted deletion of Cox-2 from specific tissues with the Cre/loxP 
system88. But the poor characterization of Cox-2 expressing cells has stalled a cell 
specific approach to the investigation of Cox-2 in the kidney to date. 
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1.3 Aims of this study  
The first aim of this study was to clearly identify and characterize Cox-2 expressing 
cells in the kidney. Specific emphasize was placed on finding markers for the medullary 
Cox-2 expressing cells. This task was in part performed to establish a selective mouse 
model in the course of this work. To this end it was necessary to ensure all Cox-2 
expressing cells of the inner medulla were included in the potential mouse model. 
Therefore, I wanted to determine which cells express Cox-2 in a stimulated setting and 
how it is regulated in adult wildtype animals. Three conditions were to be evaluated: a 
high salt diet, water deprivation for 24h and genetically induced hypoxia signaling. The 
number, cell type markers and distribution of Cox-2 expressing cells across the kidney 
was characterized in detail under these conditions with the novel RNAscope® in-situ 
hybridization technique.  
Secondly, after establishing a suitable mouse model, the role of Cox-2 in the adult 
kidney and the involvement of Cox-2 during nephrogenesis were to be investigated. In 
the global knockout model of Cox-2 as well as human fetuses exposed to NSAIDS in 
the third trimester a severe renal phenotype was reported. The phenotype presents 
with tubular hyperplasia, a large number of sclerotic glomeruli in the subcapsular 
region and interstitial fibrosis. Due to the contribution of these cells to the phenotype, I 
investigated whether Cox-2 expression during nephrogenesis in the cells of the FoxD1+ 
stromal progenitor compartment is necessary for normal kidney development and 
function. These stromal progenitor cells differentiate into interstitial cells, renin and 
mesangial cells as well as vascular smooth muscle cells. The role of this cell population 
was investigated with the help of a targeted deletion of floxed Cox-2 alleles combined 
with a cell specific Cre-recombinase for the FoxD1 compartment (FoxD1+/Cre Cox2fl/fl 
mice). 
The third part of this study was to distinguish and clarify the functional relevance of 
Cox-2 expression in medullary interstitial cells from the previously described function 
of Cox-2 in the macula densa of adult kidneys. To evaluate the function of Cox-2 in 
medullary interstitial cells I used a selective deletion of the Cox-2 gene in interstitial 
cells of the kidney with an inducible Cre-recombinase under control of the PDGFR-β 
promotor (PDGFR-β+/iCre Cox2fl/fl mice). As parameters for kidney function systolic 
blood pressure, GFR, water intake, urinary ion concentrations, -volume and key mRNA 
targets were determined and analyzed. 
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The concluding part of this study was concerned with investigating the role of resident  
Cox-2 expression in the kidney as an inflammatory mediator in the model of adenine 
induced fibrosis and unilateral ureter obstruction. Contradicting reports for the role of 
Cox-2 in pathological settings have been published to date89–92. But the source for the 
potentially disease progression relevant Cox-2 expression has not been identified due 
to the lack of an appropriate animal model91. Using a cell specific deletion, I 
investigated whether the absence of Cox-2 in PDGFR-β+ cells has any effect on the 
progression of renal fibrosis. The evaluation of disease progression was investigated 
through functional parameters, mRNA expression of fibrotic markers with qPCR and 
RNAscope® in-situ hybridization. 
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2 Material and Methods  
2.1 Material 
2.1.1 Instruments 
Instrument Manufacturer 
Anthos 2010 Microplate reader anthos Mikrosysteme GmbH, Friesoythe, Germany 
Cameras AxioCam MRm, Zeiss, Jena 
AxioCam 105 color, Zeiss, Jena 
Centrifuges Haematokrit 210, Hettich, Tuttlingen 
Tischzentrifuge, neoLab, Heidelberg 
Z300, Hermle, Wehingen 
Zentrifuge 5417R, Eppendorf, Hamburg 
Chemidoc™ Touch Imaging System Biorad, München, Germany  
Filter sets for microscopy: 
TRITC-Filter 
Cy2-Filter 
Cy3-Filter 
DAPI-Filter 
 
Filter set 43 DsRed, Zeiss, Jena 
Filter set 38 HE, Zeiss, Jena 
Filter set 50, Zeiss, Jena 
Filter set 49, Zeiss, Jena 
Fluorescent lamp Colibri.2, Zeiss Jena 
Gel Electrophorese System Compact M. Biometra, Göttingen 
Heating blocks Thermomixer, Eppendorf, Hamburg 
Thermomixer 5436, Eppendorf, Hamburg 
Heating plate HI 1220, Leica, Wetzlar 
Homogenizer Ultra-Turrax T25, Janke &Kunkel, Staufen 
Ice machine Ziegra Eismaschinen, Isernhagen 
Incubator Memmert, Schwabach 
Inhalation Device UniVet Groppler, Deggendorf, Germany  
Invitrogen™Qubit™3.0 Fluorometer Thermo Fisher Scientific, UK 
Magnetic mixer MR 80, Heidolph, Schwabach 
MR 3001 K, Heidolph, Schwabach 
Metabolic cages Tecniplast, Hohenpeißenberg, Germany 
Microscope Axio Observer.Z1, Zeiss, Jena 
Microtome Rotationsmikrotom RM2165, Leica, Wetzlar 
Rotationsmikrotom RM2265, Leica, Wetzlar 
Microwave Sharp, Osaka 
Osmomat 030 Gonotec, Germany 
PCR machine Labcycler, SensoQuest, Göttingen 
Lightcycler LC480, Roche, Mannheim 
Peristaltic pump 323, Watson Marlow, Wilmington, USA 
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2.1.2 Consumables 
Personal Computer  Dell, Intel Core i7, NVIDIA GeForce GTX1080 8 GB  
PH meter Hanna Instruments, Vöhringen 
Photometer NanoDrop 1000, Peqlab, Erlangen 
Pipettes Pipetman P2, P10, P20, P100, P200, P1000, 
Gilson, Middleton, USA 
RNAscope® oven HybEZ Oven, Advanced Cell Diagnostics, 
Hayward, USA 
Scales Feinwaage ABT 120-5DM, Kern, Balingen-Frommern 
EMS, Kern, Balingen-Frommern 
Shaker GFL, Burgwedel 
Rotamax, Heidolph, Schwabach 
Tail cuff BP measurement system Non-Invasive Blood Pressure Monitoring System, TSE 
Systems, Bad Homburg 
Vortex USA REAX1, Heidolph, Schwabach 
Water bath Aqualine AL12, Lauda, Lauda-Königshofen 
1083, GFL, Burgwedel 
Water purification MilliQ Plus PF, Millipore, Schwalbach 
XP flame photometer BWB Technologies, UK 
Product Manufacturer 
FINE-JECT 12mm, gauge 30mm VWR International, Ismaning 
Cannula 27G for hematocrit Becton Dickinson, Franklin Lakes, USA 
Minicaps end to end,  na-heparinized, 5µl Hirschmann Laborgeräte GmbH & Co. KG, 
Eberstadt 
Minicaps end to end,  na-heparinized, 0,5µl Hirschmann Laborgeräte GmbH & Co. KG, 
Eberstadt 
Cover for Pasteur pipettes Roth, Karlsruhe 
Cover slip Roth, Karlsruhe 
Dissecting tools Fine Science Tools, Heidelberg 
Filter paper Schleicher & Schuell, Dassel 
Glassware Roth, Karlsruhe 
Schott, Mainz 
Gloves Roth, Karlsruhe 
Hematocrit capillaries Sanguis Counting, Nümbrecht 
Hematocrit sealing kit Brand, Wertheim  
ImmEdge Pen Vector Laboratories, Burlingame, USA 
Microscope slides, SuperFrost® Plus Menzel, Braunschweig 
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2.1.3 Commercial kits, enzymes and chemicals 
Parafilm Bemis, Neenah, USA 
Pasteur pipettes VWR, Darmstadt 
Pipette controller accu-jet pro Brand, Wertheim 
Pipette tips with and without filter Nerbe, Winsen 
Sarstedt, Nümbrecht 
Biozym Scientific, Hessisch Oldendorf 
Plates, 96 well for qPCR Sarstedt, Nümbrecht 
Serological pipettes 5ml, 10ml, 25 ml Sarstedt, Nümbrecht 
 
Silicon forms for embedding Roth, Karlsruhe 
Syringes Becton Dickinson, Franklin Lakes, USA 
Tissue embedding cassettes Roth, Karlsruhe 
Tubes 0.5ml, 1ml, 2ml Sarstedt, Nümbrecht 
Tubes 15ml, 50ml Sarstedt, Nümbrecht 
Aspiration tube assemblies for calibrated 
microcapillary pipettes 
Sigma-Aldrich, München 
Multipurpose container 30ml Greiner Bio-One GmbH, Frickenhausen 
surgical suture Vicryl Ethicon, Norderstedt, Germany 
Product Manufacturer 
Adenine Chow (0,2%) Altromin Spezialfutter GmbH & Co. KG, Lage, 
Germany 
Agarose Sigma-Aldrich, München 
Bovine Serum Albumin (BSA) Sigma-Aldrich, München 
Chloroform Merck, Darmstadt 
Dulbecco´s PBS Sigma-Aldrich, München 
Elisa kit ANG I IBL International, Hamburg 
Enalapril maleate Sigma-Aldrich, München 
Ethanol p.a Honeywell, Morris Plains, USA 
Ethylenediaminetetraacetic acid Merck, Darmstadt 
First Strand Buffer, 5x Invitrogen, Karlsruhe 
FITC-Sinistrin Fresenius Kabi, Bad Homburg 
Formaldehyde solution (min. 37%) Merck, Darmstadt 
Gene Ruler™ 100bp plus DNA ladder Thermo Scientific, Waltham, USA 
Glycergel mounting medium (IF) Dako Cytomation, Glostrup, Dänemark 
Glycerin 87%  Merck, Darmstadt 
Glycogen Invitrogen, Karlsruhe 
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GoTaq DNA Polymerase, 5 U/μl Promega, Mannheim 
GoTaq Reaction Buffer Green Promega, Mannheim 
Hematoxylin solution, Gill Nr. 1 Sigma-Aldrich, München 
HCl 1N Merck, Darmstadt 
HCl fuming Merck, Darmstadt 
HEPES(4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) 
Sigma-Aldrich, München 
High Salt chow (4% NaCl) Ssniff, Soest, Germany 
Horse Serum (HS) Gibco, Life technologies, Grand Island, USA 
Isoflurane Baxter, Unterschleißheim 
Isopropanol Merck, Darmstadt 
Isopropanol p.a AnalaR Normapur, VWR, Radnor, USA 
Isotonic NaCl Solution, sterile 0,9% B. Braun, Melsungen 
K2HPO4 x 3 H2O Merck, Darmstadt 
Ketamine, 10% bela-pharm, Vechta 
KH2PO4 Merck, Darmstadt 
Lightcycler480®SYBR-Green-Master-PCR Kit Roche, Mannheim 
Low Salt chow (0,03% NaCl) Ssniff, Soest, Germany 
Methanol Merck, Darmstadt 
M-MLV Reverse Transcriptase, 200 U/μl Invitrogen, Karlsruhe 
Na2HPO4 Sigma-Aldrich, München 
NaCl Merck, Darmstadt 
NaH2PO4 Sigma-Aldrich, München 
NaOH 1N Merck, Darmstadt 
Oligo(dT)15 Primer, 0,5μg/μl Thermo Scientific, Waltham, USA 
Paraformaldehyde Roth, Karlsruhe 
Paraplast-Plus Paraffin Roth, Karlsruhe 
PCR Nucleotide Mix 
(dATP, dCTP, dGTP, dTTP, 10 mM each) 
Promega, Mannheim 
RNAscope® 2.5 HD Detectionreagents – 
brown 
Advanced Cell Diagnostics, Hayward, USA 
RNAscope® 2.5 HD Detectionreagents – 
duplex 
Advanced Cell Diagnostics, Hayward, USA 
RNAscope® H2O2 & Protease Plus Reagents Advanced Cell Diagnostics, Hayward, USA 
RNAscope® Target Retrieval Reagent Advanced Cell Diagnostics, Hayward, USA 
RNAscope® Wash Buffer Advanced Cell Diagnostics, Hayward, USA 
RNAscope® Multiplex Fluorescent Assay Advanced Cell Diagnostics, Hayward, USA 
Roti®-Safe GelStain Roth, Karlsruhe 
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2.1.4 Buffers and Solutions 
Unless stated otherwise, all Buffers and Solutions were prepared with purified water 
(MilliQ-Water). 
PBS (Phosphate Buffered Saline)-Otto-Buffer, pH 7,4 
NaCl 140 mM 
K2HPO4 x 3 H2O 10 mM 
KH2PO4 2,5 mM 
 
Paraformaldehyde fixation solution for immunofluorescence 
(IF), pH 7,4 
Dulbecco´s PBS  
Paraformaldehyde 3% 
 
Tris-EDTA Buffer, (epitope unmasking) pH 8,5 
Tris 9,9 mM 
EDTA 1,3 mM 
 
Stock-Solution for IF 
PBS-Otto  
BSA 1% 
 
 
Tamoxifen Chow (400mg tamoxifen 
citrate/kg) 
Harlan Laboratories, NM Horst, Niederlande 
Tris(hydroxymethyl)-aminomethan (Tris) Affymetrix, Cleveland, USA 
TRIsure®-Reagent Bioline, Luckenwalde 
VectaMount™ mounting medium (ISH) Vector Laboratories, Burlingame, USA 
Xylazine, 2% Serumwerk, Bernburg 
Xylol Merck, Darmstadt 
Xylol (for RNAscope®) AppliChem, Darmstadt 
Acidic acid 100% Sigma-Aldrich, München 
TSA Plus Cyanine 3 and Cyanine 5 System Perkin Elmer, Rehbach, Germany 
Maleic acid Sigma-Aldrich, München 
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Blocking-Solution for IF 
PBS-Otto  
BSA 1% 
Horse Serum 10% 
 
NBF fixation solution for ISH, pH 7,0 
Formalin (37-40% stock solution) 10% 
NaH2PO4 33,3 mM 
Na2HPO4 45,8 mM 
 
TAE (Tris-Acetate-EDTA) Buffer, pH 8,5 
Tris 40 mM 
Acidic acid 20 mM 
EDTA 1 mM 
 
Agarose Gel for genotyping 
TAE  
Agarose 2% 
Roti®-GelStain 0,02% 
 
HEPES Buffer for GFR, pH 7,4 
HEPES 0,5 M 
 
FITC injection solution for GFR 
NaCl solution 0,9%, sterile   
FITC 1% 
 
NaOH for genotyping 
NaOH  25 mM 
 
Tris-HCl, pH 8,0, for genotyping 
Tris 1 M 
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Maleate Buffer, pH 6,0 
Tris 33,5 mM 
maleic acid 50 mM 
EDTA 10,0 mM 
 
2.1.5 Primer for genotyping and real time pcr 
All primers were produced by Eurofins Genomics GmbH (Ebersberg) according to the 
sequences provided by us. Primers were shipped as lyophilized powder and dissolved 
in purified water to a final concentration of 100pmol/µl for all uses.  
Primer for genotyping of mice 
Construct Sequence (5´-3´) product size (bp) 
Cox-2del s   AATTACTGCTGAAGCCCACC 
as GAATCTCCTAGAACTGACTGG 
1054 = del 
Cox-2flox s   AATTACTGCTGAAGCCCACC 
as AGAAGGCTTCCCAGCTTTTGTAACC 
1058 = flox 
823 = wt 
FoxD1+/Cre s1  CTCCTCCGTGTCCTCGTC 
s2  TCTGGTCCAAGAATCCGAAG 
as  GGGAGGATTGGGAAGACAAT 
450 = Cre  
237 = wt 
PDGFR-β+/iCre 
 
s1  GAA CTG TCA CCG GCA GGA 
as  AGG CAA ATT TTG GTG TAC GG 
c1  CAA ATG TTG CTT GTC TGG TG 
c2  CTC AGT CGA GTG CAC AGT TT 
400 = Cre 
200 = internal conrtol 
CAG+/iCre 
 
s   CAGAACCTGAAGATGTTC 
as CCAGATTACGTATATCC 
286 = Cre  
Vhlflox s   CTAGGCACCGAGCTTAGAGGTTTGCG 
as CTGACTTCCACTGATGCTTGTCACAG 
450 = flox 
270 = wt 
 
Primer for quantitative Real-Time-PCR 
Gene Sequence (5´-3´) product size (bp) 
AQ2 s   CTGGCTGTCAATGCTCTCCAC 
as TTGTCACTGCGGCGCTCATC 
122 
AR s   GCAATTGCAGCCAAGTACAA 
as ATGGTGTCACCGACTTGG 
97 
BGT1 s   GGTCCTTTTGGTCACAGAG 
as GCTGGAGGCGTAGTAGTCAAA 
65 
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Col1a1 s   CTGACGCATGGCCAAGAAGA 
as ATACCTCGGGTTTCCACGTC 
91 
Cox-2 s   AGC CAT TTC CTT CTC TCC TG 
as ACA ACA ACT CCA TCC TCC TG 
894 
Cx3CR1 s   CCTGCCTCTGAGAAATGGAG 
as ATCTCTCCAGCCCCTGAAAT 
332 
ENACα s   TACGCGACAACAATCCCCAAGTGG 
as ATGGAAGACATCCAGAGATTGGAG 
334 
GAPDH s   CACCAGGGCTGCCATTTGCA 
as GCTCCACCCTTCAAGTGG 
294 
HSP70.1 s   ACCATGAAGAAGACTTTAAATAACCTTGAC 
as CCCGGTGTGGTCTAGAAAACA 
90 
PDGFR-β s   GAG GCT TAT CCG ATG CCT TCT 
as AAA CTA ACT CGC CAG CGC C 
79 
Renin s   ATGAAGGGGGTGTCTGTGGGGTC 
as ATGTCGGGGAGGGTGGGCACCTG 
194 
RPL32 s   TTA AGC GAA ACT GGC GGA AAC 
as  TTG TTG CTC CCA TAA CCG ATG 
100 
SMIT1 s   AGTGGCTTCCATGGGTCAT 
as TGCCCATTGGAATAAGCATC 
60 
UTA-1 s   TGAGACGCAGTGAAGAGGAGAA 
as ATGACCACTCGATGTGGAACAC 
141 
α-SMA s   ACTGGGACGACATGGAAAAG 
as CATCTCCAGAGTCCAGCACA 
240 
 
2.1.6 Probes for in-situ hybridization and antibodies  
Primary antibodies 
Antibody Manufacturer Dilution 
Chicken-anti-Renin Davids Biotech., Regensburg 1 : 400 
Mouse-anti-α-SMA Abcam, Cambridge, UK 1 : 600 
 
Secondary antibodies 
Antibody Conjugation Manufacturer Dilution 
Donkey-anti-chicken Cy 2 Dianova, Hamburg 1 : 400 
Donkey-anti-mouse Cy 5 Dianova, Hamburg 1 : 400 
 
  28 
Probes for in-situ hybridization with RNAscope® 
All probes were manufactured by Advanced Cell Diagnostics (Hayward, USA).  
Probe 
RNAscope® Negative Control Probe – DapB 
RNAscope® Positive Control Probe – mM-PPIB 
RNAscope® Probe – mM-Col1a1 C1 
RNAscope® Probe – mM-CSPG4 C1 & C2 
RNAscope® Probe – mM-Cx3CR1 C1 
RNAscope® Probe – mM-EPO C1& C2 
RNAscope® Probe – mM-PDGFRb C1 & C2 
RNAscope® Probe – mM-Ptgs1-O1 C1 
RNAscope® Probe – mM-Ptgs2-O1 C1& C2 
RNAscope® Probe – mM-Ren C1 & C2 
RNAscope® Probe – mM-TNC C1 & C2 
RNAscope® Probe – Rn –Ptgs2 C1 
 
2.1.7 Software and internet services  
This work was written with Microsoft Office 2016. Graphs were prepared using 
GraphPad prism 5. For microscopy, the Zen Blue software was used. Pictures were 
edited using Zen Blue and Adobe Photoshop CS5. The PubMeb site of the NCBI (The 
National Center for Biotechnology; Information: http://www.ncbi.nlm.nih.gov/pubmed/) 
was used for literature research. Citations were cataloged and organized with the 
Zotero software (version 5.0.59). 
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2.2  Methods 
2.2.1  Animals 
2.2.1.1  Mouse strains and animal breeding 
All animal experiments were conducted according to the “National Institutes of Health 
guidelines for the care and use of animals in research” and were approved by the local 
ethics committee. All mice were kept under optimal conditions, consisting of constant 
23°C room temperature, relative humidity of 55 ± 5% and a constant 12h dark/light 
cycle. Standard rodent chow (0,6% NaCl, Ssniff, Deutschland) and tab water were 
provided ad libitum unless stated otherwise. All mice were bred in a C57/Bl6 
background.  
For this work, several genetically modified mouse lines were used:  
 PDGFR-β-CreERT2 (PDGFR-β+/iCre) transgenic mice expressing a tamoxifen 
inducible Cre-recombinase under control of the PDGFR-β promoter. The 
PDGFR-β-CreERT2 is a fusion protein consisting of the Cre-recombinase and a 
modified estrogen binding site (CreERT2)14,93. Mice were kindly provided by Ralf 
H Adams, Max-Planck-Institut.  
 FoxD1tm1(GFP/cre)Amc (FoxD1+/Cre) knock-in mice express a fusion protein of Cre-
recombinase and eGFP under the endogenous FoxD1 promotor. Mice were 
purchased from Jackson Laboratories, Bar Harbor, ME, USA (Stock No: 
012463)94,95 
 CAGG-CreERT2 (CAG+/iCre) mice express a tamoxifen inducible Cre-
recombinase under control of the beta actin promoter/enhancer coupled with 
the cytomegalovirus (CMV) immediate-early enhancer. Mice were kindly 
provided by Andreas Ludwig, Pharmacology, Universität Erlangen.96  
 B6;129S4-Ptgs2tm1Hahe/J (Cox2flox) mice have loxP sites targeting exon 4 and 5 
of the Cox-2 gene. After Cre-recombination a stop codon is created in exon 6, 
disrupting gene transcription88. Mice were purchased from Jackson 
Laboratories, Bar Harbor, ME, USA (Stock No: 030785) 
 Vhlflox mice contain loxP sites, targeting the sequence coding for the promotor 
and exon 1 of von-Hippel-Lindau protein (Vhl)14,97. After Cre-recombination a 
null allele is created and transcription does not take place. Deletion of Vhl 
inhibits the proteasomal degradation of hypoxia inducible factors, stably 
inducing hypoxia signaling in the affected cells. Mice were provided by Volker 
H. Haase, Vanderbilt University, Nashville, USA. 
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For the comparison between the newly generated genotypes and Cox-2-/- mice, 
paraffin section generated in the course of previous work at the institute for physiology 
at Regensburg, were used87. No live Cox-2-/- mice were used for this work. Tissue of 
young non-albuminuric MWF rats was kindly provided by AG Castrop, institute for 
physiology, Regensburg. 
For experiments mice of both genders were used, except for the model of adenine-
induced fibrosis, where only males were used98. Animals had an average age of 15 
weeks at the time of the experiments. All newly generated genotypes were born in 
mendelian rations.   
 
2.2.1.2  Genotyping of mice 
Routine genotyping of mice was performed according to our laboratory standard 
protocol as follows by extracting genomic DNA and performing PCR. 
At the age of 4 weeks mice were labeled with ear tags and ear punch out tissue of 
approximately 3mm diameter was taken in the same step.  Ear tissue was digested in 
50µl NaOH (25mM) at 96°C for 45 minutes in a heating block. After vortexing and 
adding 10µl Tris-HCl (1M, pH 8,0), samples were centrifuged 6 min at 10000 rpm. For 
PCR 0,5µl of the supernatant was used. 
25 µl PCR mixture 
5 µl GoTaq Buffer 
0,75 µl for each  Primer (10pmol/µl) 
2 µl dNTPs (2,5mM) 
0,2 µl GoTaq 
0,5 µl gDNA 
ad 25 µl MilliQ-H2O 
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PCR-running-programm 
number of 
cycles 
Duration Temperature Phase 
1 5 min 94 °C activation 
┌  30-60 s 94 °C denaturation 
36 30-60 s x °C annealing  
└ 30-50 s 72 °C elongation 
1 10 min 72 °C elongation 
1 ∞ 4 °C storage 
 
Primer specific annealing temperatures 
PCR Temperature 
Cox2del 56 °C 
Cox2flox 61 °C 
FoxD1+/Cre 58 °C 
CAG+/iCre 54 °C 
PDGFR-β+/iCre 56 °C  
Vhlflox 62 °C 
 
For separation of the resulting products, 10µl PCR mixture were applied to a 2% 
Agarose gel and separated by horizontal electrophoresis with 130V in TAE running 
buffer. 
 
2.2.1.3  Induction of Cre-Recombinase activity with tamoxifen 
To activate the inducible Cre-recombinases used in this work, namely PDGFR-β+/iCre 
and CAG+/iCre, mice aged 8 weeks, were fed a tamoxifen containing diet (400mg/kg 
tamoxifen citrate) for 4 weeks. This was followed by a 3 week rest period on normal 
rodent diet (0,6% NaCl) to ensure that any observed effects were not caused by 
tamoxifen. 
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2.2.1.4  High salt diet 
To test the reaction of the generated mouse strain to a salt stimulus, after induction of 
Cre-recombinase activity and the following rest period, mice were fed a diet containing 
4% NaCl for 14 days. Experiments were performed on day 14 unless stated otherwise. 
2.2.1.5  Treatment with low salt diet and Enalapril  
In order to stimulate the RAAS, animals were treated with a low salt diet containing 
0,03% NaCl for 10 days. Additionally 50 mg/L of the ACE-inhibitor enalapril was added 
to the drinking water for the same period. Experiments were performed on day 10 
unless stated otherwise. 
2.2.1.6  Adenine-induced kidney fibrosis 
For studying the effects of the targeted deletion of Cox-2 in the kidney on the 
progression of fibrosis, the model of adenine-induced fibrosis was used98–100. After 
tamoxifen induction of Cre-recombinase and the following rest period, male mice were 
fed adenine containing diet (0,2%) for 3 weeks.  Experiments were performed after 
exactly 3 weeks (3wks adenine) or after an additional 3 weeks in which the mice were 
again feed a normal diet (3wks adenine + 3wks). 
2.2.1.7  Water deprivation for 24h 
To induce Cox-2 expression in the inner medulla and evaluate the osmotic stress 
response of the mice, they were deprived of drinking water for 24h and killed 
immediately after this time period.  
2.2.1.8  Unilateral ureteral obstruction 
Mice were anesthetized with 2% isoflurane inhalation and placed on a 37°C warming 
plate. An anesthetic mask was placed over the nose of the mouse to ensure a 
continuous application of isoflurane for the duration of the procedure.  
To ligate the right ureter a small incision was made over the approximate location of 
the ureter. The skin was carefully retracted and the ureter located with a soft Q-tip to 
avoid internal damage. A double knotted ligature was placed on the ureter and the skin 
was sewed up twice to prevent an opening of the wound. Mice were kept under 
observation for 2h after the operation and then daily checked to ensure wellbeing.  
2.2.1.9  GFR measurement 
To measure the glomerular filtration rate (GFR) in conscious mice, a slightly modified 
protocol utilizing the clearance of FITC-Sinistrin by the kidney101 was used. This 
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technique makes it possible to repeatedly measure the GFR of the same mouse. Thus 
changes in GFR in the same mouse between different treatments could be evaluated. 
Briefly, mice were immobilized for two minutes in 4% isoflurane inhalation anesthesia. 
While the mice were unconscious a single bolus injection of FITC-Sinistrin, adjusted to 
the bodyweight (BW), was given in the tail vein. Mice were then placed in a  heated 
chamber, leaving access to the tail. Mice were awake and active within one minute 
after the bolus injection. Blood samples were collected 3,7,10,15,35,55 and 75 min 
after the injection into 5µl capillaries from the tail vein. After collection, blood samples 
were centrifuged at 12000 rpm for 7min. 0,5µl of the resulting plasma were diluted in 
HEPES-Buffer and the FITC-Sinistrin fluorescence in the samples was measured with 
a Qubit™ 3.0 Fluorometer. GFR of mice was calculated by applying the two-
compartment model. To get a better comparison between mice, especially when of 
different gender, GFR/BW was calculated and used for analysis.  
 
2.2.2 Retrograde arterial perfusion of mice  
To fix kidney tissue for histological evaluation, mice were perfused with either 3% 
paraformaldehyde (pH 7,4) for immunofluorescence, or with 10% NBF solution (pH 
7,0) if the tissue was used for in-situ hybridization with the RNAscope® technology. 
Mice were first anesthetized with an i.p injection of Ketamine (80mg/kg BW) and 
Xylazine (16mg/kg BW).  After opening the abdominal cavity and exposing the 
abdominal aorta the left kidney was ligated to preserve the tissue for mRNA extraction. 
A clamp was placed on the aorta just below the branching of the kidney arteries 
(Arteriae renales) to preserve the kidney perfusion. The aorta abdominalis was 
carefully opened below the clamp with scissors and a perfusion catheter was inserted 
into the aorta with the help of a vessel dilator and fixed with a clamp. After removing 
the upper clamp the vena cava inferior is opened below the catheter to equilibrate the 
pressure. Continous perfusion of the kidney with a steady flow of 13ml/min and a total 
volume of 40ml fixation solution was started. After the perfusion the ligated left kidney 
was removed, cut in half and snap frozen with liquid nitrogen. Tissue was stored at -
80°C until used. The perfused kidney was removed, cut in half and stored either in 
70% Methanol (for IF) at 4°C or in NBF (ISH) at RT for 16-24h before embedding in 
paraffin.   
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2.2.3  Zonal dissection of kidneys 
To determine the zonal distribution of different mRNA targets, kidneys were dissected 
into three zones after removal from the mouse. The kidneys were halved and thin slices 
were prepared with a razorblade and immediately transferred into petri dish containing 
10ml ice-cold sterile NaCl 0,9% solution. Under a microscope, the thin kidney slices 
were then separated with a razorblade into cortex, outer medulla and inner medulla. 
At least four slices per kidney were dissected, the tissue was then pooled by zone into 
a cup and snap frozen in liquid nitrogen. Tissue was stored the same as complete 
kidneys at -80°C for mRNA extraction.  
2.2.4  Tail cuff blood pressure measurement 
Blood pressure measurements were performed on conscious mice with tail cuff 
manometry. Briefly, mice were placed in a restraining chamber, giving free access to 
the tail, the measurement probe and inflatable pressure cuff were placed over the tail 
and the mouse was left for 5 min to rest. Performing this procedure at the same time 
each day the mice were acclimatized to the measurement procedure for five days. 
Then on each day for the duration stated in the experiments, five measurements were 
performed per mouse and a mean of these measurements was used for evaluation of 
the results.  
2.2.5  Metabolic cages 
For determination of 24h urine volume and the corresponding water intake, mice were 
housed in individual metabolic cages. Each cage was pre-treated with a thin silicon 
film in the lower part to facilitate a better separation of urine and fecal matter into 
separate containers. The mice were given a house for better acclimatization and feed 
sufficient for one day along with a weighted water bottle. Each morning mice were 
transferred to a fresh cage, urine was collected and water intake calculated by 
weighing the water bottle again. Mice were placed in the cages for two days before the 
measurement period, undergoing the entire procedure to get them acclimatized. 
Unless stated otherwise, 5 days of urine collection and water intake were measured 
for each mouse per condition. 
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2.2.6  Spot urine collection and analysis 
Mice were placed in a clean plastic box with a lid each day for 3 consecutive days to 
collect urine samples. If the mice did not urinate spontaneously (spot urine) after 15min 
in the box, they were placed back into the cage and the procedure was repeated the 
next day. Samples were frozen at -80°C until analysis.  
2.2.6.1 Osmolality measurement  
Urine osmolality was determined by freezing point depression. 5µl urine were diluted 
in 45µl Millipore-H2O, vortexed and measured in the Osmomat 030. Resulting values 
were multiplied with the dilution and converted to mOsmol/l for evaluation.  
2.2.6.2 Sodium and potassium measurement in urine 
The concentration of sodium and potassium in urine was determined simultaneously 
by flame photometry. Before the measurement, the instrument was calibrated with 
standard dilutions (5 point, linear dilution) made from commercial stocks for both ions. 
10µl urine were diluted in 10ml MilliQ-H2O, vortexed and then measured in duplicates. 
The mean values were multiplied with the dilution and converted to mMol/l for 
evaluation of the results.  
 
2.2.7  Histological methods 
2.2.7.1 Embedding of tissue in paraffin 
For embedding the perfused tissue in paraffin, the halved kidneys were transferred to 
embedding cassettes and dehydrated in an ascending alcohol series. 
Time, temperature in-situ hybridization  immunofluorescence  
1 x 30 min, RT 70% Ethanol p.a. 70% Methanol 
2 x 30 min, RT 80% Ethanol p.a. 80% Methanol 
2 x 30 min, RT 90% Ethanol p.a. 90% Methanol 
2 x 30 min, RT 100% Ethanol p.a. 100% Methanol 
2 x 30 min, RT 100% Isopropanol p.a. 100% Isopropanol  
1 x 30 min, 45 °C 100% Isopropanol p.a. 100% Isopropanol 
1 x 30 min, 60 °C 1 : 1 Isopropanol/paraffin 1 : 1 Isopropanol/paraffin 
2 x 24h, 60 °C Paraffin Paraffin 
Kidneys were then placed in silicon forms with liquid paraffin, the cut surface facing 
down. Paraffin was left to solidify overnight, blocks were then removed from the silicon 
forms and stored at RT.  
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2.2.7.2 Section of paraffin embedded tissue 
Tissue blocks were roughly trimmed with a razorblade before placing them in the 
microtome holder and firmly screwed into place. Sections of 5µm thickness were 
prepared from the tissue and carefully placed in a 41°C water bath to stretch out 
wrinkles in the tissue. Sections were then placed on SuperFrost® Plus slides with a 
brush and dried overnight at room temperature.  
2.2.7.3 Immunofluorescence staining 
Immunofluorescence staining was used to visualize protein structures in the kidney 
tissue studied. For this aim indirect immunofluorescence with two antibodies (AB) was 
used, the primary antibody binding to the target epitope in the tissue and the secondary 
antibody reacting specifically with the primary AB. To make the target visible for 
microscopy the secondary AB is conjugated to a fluorescent dye to show a strong 
fluorescence when exited with light at distinct wavelengths. Before the incubation of 
the primary AB the paraffin was removed and the tissue rehydrated by a decreasing 
alcohol series. 
Time Solution 
2 x 10 min 100% Xylol  
2 x 5 min 100% Isopropanol 
1 x 5 min 90% Isopropanol 
1 x 5 min 80% Isopropanol 
1 x 5 min 70% Isopropanol 
1 x 5 min MilliQ-H2O 
 
Staining was then performed according to a standard protocol:  
 3 x 10 min washing in PBS-Otto Buffer  
 Creating a hydrophobic barrier around the tissue  
 Blocking unspecific binding sites for 30 min with the IF blocking solution (10% 
HS, 1% BSA in PBS-Otto) at RT 
 Incubation of the primary AB diluted in blocking solution overnight at 4°C 
 Remove the primary AB by washing 3 x 5 min in Stock solution (1% BSA in 
PBS-Otto) 
 Incubation of the secondary AB, diluted in stock solution, for 1,5h in the dark at 
RT 
 Remove the secondary AB by 3 x 5 min washing in PBS-Otto Buffer in the dark 
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 Mount slides with pre-warmed mounting medium and dry overnight at 4°C 
 
2.2.7.4 Sirius Red staining  
For the visualization of collagens, Picro-Sirius-Red staining (SR) was performed. 
Tissue sections of 5µm thickness were deparaffinized as described above for 
immunofluorescence staining. Slides were placed in the SR-solution for 1h at room 
temperature. After the incubation two short wash steps in 0,5% acidic acid were 
performed, followed by two wash steps in isopropanol (p.a). To remove residual water 
slides were placed in xylol and then immediately mounted with cover slides and left to 
dry under a fume hood.   
2.2.8  In-situ hybridization utilizing the RNAscope® technique 
With the RNAscope® in-situ hybridization method, mRNA for different targets was 
made visible on kidney tissue. This technique was used to localize and co-localize the 
expression of different mRNA throughout the kidney tissue. This form of in-situ 
hybridization was performed according the manufacturer´s protocol with minor 
changes102. Probes for in-situ hybridization were mixed and diluted according to the 
manufacturer´s protocol and are described in the individual experiments. Negative 
controls routinely did not show any positive signal.  
2.2.8.1 Chromogenic and duplex RNAscope 
For in-situ hybridization using the RNAscope® 2.5 HD Reagent Kit (brown or red) 
RNAscope® 2.5 HD Reagent Kit (Duplex Assay) or Multiplex Fluorescent Assay slides 
received the same pre-treatment:  
 Slides were incubated for 60 min at 60°C in dry heat 
 To remove paraffin slides were washed 2 x 10 min in Xylol (RT) then 2 x 2 min 
in 100% Ethanol p.a. 
 Sections were air-dried for 5 min  
 All sections were covered with RNAscope® Hydrogenperoxide (RT) for 10 min 
 Slides were washed twice in MilliQ-H2O  
 Placed in a holding cassette the slides were submerged and boiled (98-102°C) 
in RNAscope® 1x Target Retrieval-Solution for 15 min 
 After briefly washing in MilliQ-H2O and 100% Ethanol p.a., sections were air-
dried  
 Single tissue sections were surrounded by a hydrophobic barrier  
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 Directly, or on the next day the sections were incubated for 30 min with 
RNAscope® Protease Plus (40°C) 
 Slides were washed in MilliQ-H2O 
 After application of the probe (red or brown kit) or the probe mixture (for duplex 
assay and Fluorescent Assay) the slides were incubated for 2h in the 
hybridization oven 
 Each step was then followed by 2 x 2 min washing in 1 x RNAscope® Washing 
Buffer 
o AMP 1: 30 min (40°C) 
o AMP 2: 15 min (40°C) 
o AMP 3: 30 min (40°C) 
o AMP 4: 15 min (40°C) 
o AMP 5: 45 min (RT) 
o AMP 6: 15 min (RT)  
Slides treated for the brown/red single color kit underwent signal detection at this point 
by applying the DAB-Substrate solution (30µl per section) for 10 min and then 
counterstaining the slides as in the duplex assay 
 Slides treated with the duplex assay kit underwent detection of the channel 2 
(C2) red signal at this point by applying the Fast Red mixture (30µl per section) 
for 10 min  
 After washing for 2 x 2 min in 1 x RNAscope® Washing Buffer, the green signal 
was amplified by the following steps, each was again followed by a washing 
step  
o AMP 7: 15 min (40°C) 
o AMP 8: 30 min (40°C) 
o AMP 9: 30 min (RT) 
o AMP 10: 15 min (RT) 
 Incubation of the Fast Green detection mixture (30µl per section) on the slides 
for 10 min visualized the channel 1 green signal  
 Slides were placed in 50% Hematoxylin solution for 30s then washed very fast 
3 times in MilliQ-H2O and counterstained in 0,02% NH4OH solution for 10s  
 After drying for 20 min at 60°C in dry heat, the slides were mounted with 
VectaMountTM mounting medium and dried at RT overnight 
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2.2.8.2 RNAscope® Multiplex Fluorescent Assay 
Slides for the RNAscope® Multiplex Fluorescent Assay were pre-treated in the same 
manner as described above, with the exception that here protease IV used instead of 
protease plus. After 2h incubation of the probes the amplification, blocking and 
detection steps were performed per the manufacturer´s protocol. Detection of the 
probes was performed with the PerkinElmer fluorophores according to the protocol. 
For these slides, no counterstaining with hematoxylin was performed, but nuclei were 
visualized by staining with the DAPI solution included in the RNAscope® Multiplex 
Fluorescent Assay. 
 
2.2.9  Microscopy 
2.2.9.1 Microscopy for fluorescent dyes 
All tissue treated with fluorescent dyes was viewed with a Axio Observer.Z1-
Mikroscope fitted with a motorized slide table and a black-white-CCD-Camera 
(AxioCam MRm), using the ZEN blue (2012) Software. Using different filters the 
different fluorophores were excited at their optimal wavelength and the resulting 
emissions captured. In the case of multiple fluorophores being used on the same 
tissue, the different channels were captured separately, merged and then converted to 
a RGB-Color scheme.   
Fluorophore Excitation (nm) Emmission (nm) 
Cy 2 450 – 490 500 – 550 
TRITC 533 – 558 570 – 640 
Cy 5  625 – 655 665 – 715 
DAPI 335 – 383  420 – 470  
 
2.2.9.2 Microscopy for RNAscope® 2.5 HD Reagent Kit (brow/duplex) 
Tissue with a chromogenic in-situ hybridization was viewed with the same microscope 
as described above, but an Axiocam 105 color camera was used to capture the 
images. All overviews showing whole kidney sections were made by stitching tiles with 
a 200x magnification together using the tile function in ZEN blue (2012). 
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2.2.10 Molecular biology methods 
2.2.10.1 Measurement of mRNA expression levels and cDNA synthesis 
The protocol for the isolation of the whole RNA content of kidneys is based on the 
guanidine thiocyanate-Phenol-Chloroform-Method that has been previously 
described103 with some modifications.  
First the still frozen tissue was homogenized in TRIsure®-reagent (1ml), a single phase 
mixture of Phenol and guanidine thiocyanate. All steps were performed on ice, unless 
stated otherwise. After the addition of chloroform (200µl) a centrifugation step (30min, 
13000rpm) was performed to separate the solution into three phases. DNA and 
hydrophobic proteins remain in the green phenol phase at the bottom, followed by a 
white interphase consisting of hydrophilic proteins and a aqueous phase containing 
RNA. The aqueous phase was removed and added to 500µl Isopropanol and 2µl 
Glycogen to precipitate the RNA. After centrifugation of the RNA (30min, 13000rpm) 
and washing (1ml 75% Ethanol p.a.), repeated centrifugation (30min, 13000rpm), 
Ethanol was removed and RNA pellets were air-dried and dissolved in MilliQ-H2O. RNA 
was stored at -80°C for further use.  
Total isolated RNA content was quantified with a nanodrop photometer. To this end 
the optical density of the RNA solution was measured at 260 nm and 280 nm. Optimal 
concentration of the RNA for accurate pipetting in the following experiments was set 
to 1µg/µl. To evaluate the quality of the obtained RNA the absorption ratio between 
260 nm and 280 nm was used. Only RNA with a ratio between 1,5 to 2,0 was used for 
the experiments in this work.   
To ensure only mRNA was transcribed into the complimentary cDNA by reveres 
transcriptase, Oligo(dT)15-Primer were used to selectively amplify the 3´-poly(A)-tail of 
the isolated mRNA. The cDNA was synthesized using a 10µl reaction mixture 
containing RNA (1µg), Oligo(dT)15-Primer (1µl) and MilliQ-H2O (ad 10µl). This mixture 
was placed in a thermocycler for 5 min at 65°C to bind the primer. After short 
centrifugation, the samples were placed on ice and 10µl master mix (4µl FSB, 1µl 
10mmol dNTP-mix, 1µl reverse transcriptase, 4µl MilliQ-H2O) was added to each 
sample. Synthesis of cDNA was performed for 1h at 37°C followed by inactivation of 
the reverse transcriptase through heating the samples for 2 min to 94°C. The resulting 
cDNA was diluted with 35µl MilliQ-H2O and stored at -20°C.  
  41 
2.2.10.2 Quantitative real time PCR 
For quantitative real time PCR the LightCycler® 480 SYBR Green I Master Kit was 
used in this work. To quantify the exponential increase in DNA content of the samples 
with each cycle in real time, the DNA content is assessed with photometry. This is 
possible through the high affinity intercalation of the SYBR Green Dye with the small 
furrow of double strand DNA. The fluorescence of SYBR Green bound to DNA is 1000x 
increased compared to unbound SYBR Green. Thus the intensity of the fluorescent 
signal is proportional to the DNA content in the sample. Real time PCR was performed 
with specific primers for each target in a Roche LightCycler LC480® Instrument, 
following a standard protocol.  
Real time PCR reaction mixture per sample  
 5µl LightCycler® 480 SYBR Green I Master 
 0,5µl sense-Primer (10 pmol) 
 0,5µl antisense-Primer (10 pmol) 
 3µl MilliQ-H2O 
 1 µl cDNA 
Amplification protocol 
Cycle Temperature  Duration  Phase 
1 95 °C 5 min activation 
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95 °C 15 s denaturation 
62 °C 20 s annealing 
72 °C 20 s elongation 
After the end of the amplification protocol, a melting curve was run on the samples to 
check for product purity. The amplified DNA was slowly heated in 0,1 °C/s steps from 
60 °C to 95 °C with continuous measurement of the fluorescence in the sample.  
 
2.2.11 Measurement of plasma parameters 
2.2.11.1 Blood sample collection 
Blood samples for evaluation of hematocrit values and plasma collection were taken 
from adult mice at predetermined times. Blood was collected into EDTA coated 
capillaries from the tail vein. Capillaries were firmly capped with sealing kit on one side 
and centrifuged at 12000rpm for 4 min to separate plasma and solid blood cells. 
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Hematocrit values were taken as the ratio between total volume and solid blood cells. 
Plasma was removed from the capillaries and stored in cups at –80°C until further use.   
 
2.2.11.2 Renin-ELISA 
The Renin concentration in plasma samples was measured indirectly by quantifying 
the amount of ANG I produced by a plasma sample in the presence of excess 
substrate. ANG I content was determined by ELISA. For ANG I production, plasma 
was diluted in maleate buffer and PMSF and incubated with renin-substrate and 
generation buffer. Renin-substrate was isolated from plasma of double 
nephrectomized male rats. Two reaction mixtures were prepared for each sample. One 
was incubated at 37°C for 90min and the other was left on ice for the same time. Of 
each samples, both cold and warm, 45µl were used in the ELISA for the quantification 
of ANG I, according to the manufacturer´s protocol. Calculation of renin concentration 
in the plasma samples, stated as ngANG I/min*h-1, was done as described in the manual. 
 
2.2.12 Statistics 
For each experiment the single values for each mouse were used to calculate a mean 
value and standard deviation of the mean per genotype, unless stated otherwise. 
Student’s t-test was used to determine significance between experimental groups. 
Significant difference between groups was defined at p<0,05 and labeled with (*) in 
graphs.  
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3 Results 
3.1 Localization of Cox-2 in the kidney and characterization of Cox-2 expressing 
cells 
In the murine kidney different expression sites for Cox-2 have been described4,23,104. 
One location for Cox-2 expression in the kidney are the macula densa cells of the JGA 
in the cortex3,4,18,21. Various studies have also described the expression of Cox-2 in 
medullary interstitial cells4,23,46,58 or collecting ducts53,80,105 but no systematic 
investigation into the characteristics of the cells expressing Cox-2 in the inner medulla 
or their origin has been performed to date.  
To clarify the nature and characteristics of Cox-2 expressing cells in the inner medulla, 
I utilized the novel RNAscope® technique to study these cells regarding the co-
expression of other markers. Furthermore I used this technique to compare the two 
most used rodent laboratory animals, concerning differences in Cox-2 expression.   
In the kidneys of adult wildtype mice Cox-2 expression could only be detected in the 
macula densa cells of the cortex (Figure 6,D) and in interstitial cells in the inner medulla 
(Figure 6,A). By using the RNAscope® 2.5 HD Duplex and Mulitplex Assay to detect 
two target mRNA at the same time, I found that these interstitial cells are not only 
double positive for Cox-2 and PDGFR-β, but that they also express the glycoprotein 
tenascin-C (TNC) (Figure 6,B and C). In Cox-2+ macula densa cells no co-expression 
with PDGFR-β or TNC could be detected. 
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Quantitative analysis of the co-localization images showed that about 90% of Cox-2 
expressing cells of the inner medulla also express PDGFR-β (Figure 7). 
 
Figure 6: Localization of Cox-2 in medullary interstitial cells of the mouse kidney, brown signal denotes Cox-2 
mRNA location (A); co-localization of Cox-2 (red) and PDGFR-β (green) mRNA marked with arrows in interstitial 
cells at the border between inner and outer medulla (B); TNC (green) and Cox-2 (red) mRNA can be detected in 
the same interstitial cells of the inner medulla (C); in cells of the macula densa no co-localization between Cox-2 
(green, arrows) and PDGFR-β (red) could be detected (D); scale bar 50µm 
Figure 7: Quantitative co-localization of Cox-2 and PDGFR-β showed that the vast majority of Cox-2 expressing 
cells in the inner medulla also express PDGFR-β (left; 337 cells with PDGFR-β vs. 52,5 without; n = 3); in the  outer 
medulla co-localization between PDGFR-β and Cox-2 is even more pronounced (right; 74 cells with PDGFR-β vs. 
7,5 without; n = 3) 
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Further investigation into these interstitial cells showed a 98% overlap between 
PDGFR-β and TNC (Figure 8;left side) in the inner medulla and the inner stripe of the 
outer medulla. TNC is only expressed by interstitial cells in these areas, but not by 
interstitial PDGFR-β+ cell of the cortex. Therefore, I conclude that there is no 
subpopulation that expresses PDGFR-β and Cox-2, but not TNC among the interstitial 
cells of the inner medulla.   
 
The Cox-2+ interstitial cells showed only occasional co-expression of NG2, which has 
been described as a marker of interstitial cells12,106 besides PDGFR-β (Figure 8;right 
side). No Cox-2 mRNA was detected in collecting duct cells or other non-interstitial 
cells of the medulla. 
Co-in-situ hybridization for Cox-1 and Cox-2 mRNA showed that, although Cox-1 is 
expressed much more abundantly than Cox-2, the intracellular overlap for the two 
isoforms is minimal (Figure 9). Cox-1 expression in the collecting duct of the inner 
medulla was accompanied by Cox-2 in the surrounding interstitial cells. Only few Cox-
1 signals could be detected in the Cox-2+ cells. In the cortex, interstitial cells showed 
a weak Cox-1 signal. But in all co-localization experiments no Cox-2 mRNA was 
detected in interstitial cells outside the area of the inner and outer medulla or the 
macula densa cells in the cortex (Figure 10).  
 
Figure 8: Between PDGFR-β (red) and TNC (green) a co-localization of 98% could be detected in the inner and 
outer medulla (left); in the interstitial Cox-2 expressing cells (red) of the inner medulla only an occasional co-
expression with NG2 (green) could be observed (right); scale bar 50µm 
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Figure 9: Co-localization of Cox-1 (green) and Cox-2 (red) mRNA; in the kidney cortex (A) Cox-1 expression was 
detected in distinct tubular compartments, intraglomerular and to a lesser degree in interstitial cells. In cells of the 
macula densa no overlap between Cox-1 and Cox-2 occurred (arrows); the inner medulla of wildtype mice (B) 
showed a strong Cox-1 expression in the collecting duct, Cox-2 positive interstitial cells (arrows) were located 
around the tubules and showed only weak Cox-1 expression; scale bar 20µm 
Figure 10: Whole kidney section of an adult wildtype mouse with a normal salt diet; red markings emphasize Cox-
2 mRNA expressing cells and were placed over the original signal after imaging; Cox-2 mRNA was only detected 
in the interstitial cells of the inner and outer medulla and in cells of the macula densa in the kidney cortex; scale 
bar 500µm 
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Due to the locally restricted interstitial expression of Cox-2 no co-localization between 
Cox-2 expressing cells and interstitial fibroblast like cells expressing PDGFR-β and 
CD73 in the cortex could be detected (data not shown).  
These findings support my definition of medullary Cox-2 expressing cells as interstitial 
pericytes or fibroblast like cells expressing PDGFR-β and TNC, but not CD73. 
To gain a better perspective of the results obtained for mice in this study I performed 
an exploratory in-situ hybridization, comparing the Cox-2 expression in mice with the 
expression in rats. Rats have been used for numerous studies concerning Cox-2 to 
date, but no expression comparison between the two animal models has been 
conducted to my knowledge.  
 
Figure 11: For comparison of different laboratory animal models, Cox-2 mRNA (green) was located on mouse (A 
and C) and rat (B and D) tissue; in rat kidneys Cox-2 expression in the macula densa was much stronger (B) than 
in mice (A); glomeruli are marked by dotted lines; additionally rat kidneys show a weak Cox-2 expression in the 
glomerulus, that is completely absent in mice; in the inner medulla Cox-2 expression in rat kidneys (D) is also much 
stronger under basal conditions than in mice (C) while the localization of Cox-2 is also restricted to interstitial cells; 
scale bar 50µm 
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The amount of Cox-2 expressed in rat kidney’s is much higher under basal conditions 
for both expression sites, macula densa and medullary, than in mice (Figure 11). 
Additionally Cox-2 is expressed intraglomerular in rats, which is not the case for mice. 
But the collecting duct cells of rats were also free of any Cox-2 signal.  
 
3.2  Regulation of Cox-2 expression in the kidney  
A number of factors tightly modulate the renal Cox-2 expression. In the macula densa 
cells a salt deficient diet has been reported to increase Cox-2 expression4,6,23. 
Conversely, a high salt diet lowers the expression of Cox-2 in the cortex. The 
expression of Cox-2 in the kidney medulla seems to be regulated in a reverse 
fashion44,104. Stabilization of the hypoxia inducible factors (HIF) has been shown to 
induce the expression of Cox-2 in the kidney17,53 and other tissues55. No localization 
for the hypoxia induced Cox-2 expression in the kidney was known to date.  
It was an aim of this study to investigate in which cells a recruitment or regulation of 
Cox-2 takes place under certain challenges. Focus has been placed on the type, 
number and location of Cox-2+ cells in each condition. It was evaluated whether an 
increase in Cox-2 mRNA is caused by more Cox-2 expression per cell or the 
recruitment of additional Cox-2 expressing cells.  
Using in-situ hybridization, I analyzed the expression pattern of Cox-2 on whole kidney 
sections of wildtype mice with a normal or high salt diet, after 24h water restriction and 
of mice with a genetically activated hypoxia signaling pathway.  
The strongly increased expression of Cox-2 mRNA in the medulla of mice fed a high 
salt diet or after 24h water restriction was caused by a recruitment of additional cells 
producing Cox-2 as well as an increased mRNA production per cell (Figure 12).  
 
Figure 12: Basal expression of low levels of Cox-2 (brown signal) in the inner medulla (left), recruitment of additional 
Cox-2 expressing cells after water deprivation and increased Cox-2 production per cell (middle), maximal 
physiological recruitment and Cox-2 production under a high salt diet (right); scale bar 50µm  
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Additionally recruited Cox-2 expressing cells were localized in the inner medulla and 
the inner stripe of the outer medulla (Figure 13, B-D). After 24h water deprivation a 
marked increase in the number of Cox-2+ cells could be detected, but the maximal 
physiological induction of Cox-2 expression in the medulla was observed after 14d high 
salt diet (Figure 13,B and C, Figure 15). 
 
The additional expression of Cox-2 was present only in PDGFR-β and TNC positive 
cells, no further subset of inducible Cox-2 expressing cells could be detected under 
any of these conditions (Figure 14).  
 
Figure 13: Kidney section of a wildtype mouse fed a normal salt diet, Cox-2 mRNA was marked in red (A); 
recruitment of additional Cox-2 expressing cells can be observed especially in the inner medulla after 24h water 
deprivation (B); maximal recruitment of Cox-2 expressing cells in mice fed a high salt diet (C); Cox-2 expression in 
mice with genetically activated hypoxia signaling pathway after deletion of Vhl in PDGFR-β+ cells (D); scale bar 
500µm 
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Deletion of the Vhl gene leads to stabilization of hypoxia inducible factors (HIFs)1,55. 
These HIFs control the expression of numerous hypoxia inducible gene-targets such 
as EPO and Cox-217,55. Under the genetically induced hypoxia in PDGFR-β+ cells 
(PDGFR-β+/iCre Vhlfl/fl mice), an increase in medullary Cox-2 expression was observed 
(Figure 13, Figure 15). Besides an increase in Cox-2 expression these mice were 
severely polycythemic1 due to heightened EPO production in newly recruited EPO 
producing PDGFR-β+ cells. 
Figure 14: Recruitment of additional Cox-2 expressing cells (green) in the inner medulla after high salt diet was 
observed only in cells also positive for PDGFR-β (red) examples are marked with arrows, but not in tubular cells or 
other kidney structures; nuclei were counterstained with DAPI (blue); scale bar 20µm 
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Closer investigation of the EPO producing cells that are located in the inner and outer 
medulla of PDGFR-β+/iCre Vhlfl/fl mice showed a substantial number of PDGFR-β+ cells 
that are able to express EPO and Cox-2 at the same time. These were located mostly 
in the outer medulla (Figure 16). 
 
From these findings I conclude that PDGFR-β+ interstitial cells are the only cell type 
able to express Cox-2 in the inner and outer medulla of the murine kidney under the 
four conditions mentioned above. Recruitment of additional Cox-2 expressing cells is 
only possible in other PDGFR-β+ cells and is locally restricted to the inner and outer 
Figure 15: Number and location of recruited Cox-2 expressing cells; the maximal induction of Cox-2 expression can 
be observed after feeding mice a high salt diet; chronic hypoxia signaling by deletion of the Vhl gene leads to a 
recruitment of Cox-2 cells mainly in the outer medulla; n = 3 for each condition 
Figure 16: Expression of EPO (green) and Cox-2 (red) mRNA in cells of the outer medulla of PDGFR-β+/iCre Vhlfl/fl 
mice (left); percentage of counted cells with EPO and Cox-2 mRNA in the inner and outer medulla of PDGFR-β+/iCre 
Vhlfl/fl mice; cells expressing both mRNAs at the same time were mostly located in the outer medulla (right); n = 4; 
scale bar 50µm 
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medulla. Interstitial cells of the kidney cortex that express CD73 besides PDGFR-β, 
but not TNC, seem incapable to express Cox-2 regardless of the stimulus.  
Furthermore, there seems to be a subset of PDGFR-β+ cells that is in principal able to 
produce EPO and Cox-2 at the same time, but these are distinct from the majority of 
EPO producing cells in PDGFR-β+/iCre Vhlfl/fl mice by their location in the medulla and 
lack of CD73 expression. 
 
3.3  Importance of Cox-2 for kidney development and function 
3.3.1 Function of Cox-2 investigated by conditional gene deletion in specific 
compartments 
The two distinct expression compartments for Cox-2 identified in the first part of this 
work, macula densa cells and medullary interstitial cells, give rise to the theory that 
they serve different functions.  
It was the second aim of this study to find a suitable mouse model, allowing the 
separate investigation of the Cox-2 function in its two expression sites. Through the 
targeted deletion of the Cox-2 expression in distinct cell types the different functions of 
Cox-2 were investigated more closely. 
 
3.3.1.1 Conditional deletion of Cox-2 in all cells of the adult kidney  
For the conditional deletion of Cox-2 a mouse model with floxed Cox-2 alleles was 
used as first described by Ishikawa et al88. In this model exon 4 and 5 of the Cox-2 
gene can be excised by a Cre-recombinase, leading to a frameshift and a stop codon 
in exon 6. 
To evaluate the efficiency of the deletion of the Cox-2 gene, I first crossed these mice 
with mice bearing CAG+/iCre, an ubiquitously expressed tamoxifen inducible Cre-
recombinase (CAG+/iCre Cox2fl/fl mice). After induction of Cre-activity, Cox-2 mRNA 
abundance was drastically reduced across all kidney zones (Figure 17). 
A specific RNAscope® probe was generated to bind in the mRNA section after exon 6, 
so a positive Cox-2 signal is only achieved in cells expressing functional Cox-2 mRNA 
(Figure 17).  
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To further verify the successful excision of the Cox-2 gene, genotyping for the gene 
sequence newly created after recombination, as described previously88, was 
performed for all experimental animals (Figure 18).  
 
With these data I conclude that the mouse models made up of a Cre-recombinase and 
floxed Cox-2 alleles yield a sufficient reduction of Cox-2 expression to study the 
function of Cox-2 in the so targeted cells.  
 
Figure 17: Cox-2 mRNA abundance was greatly reduced in the inner medulla of CAG+/iCre Cox2fl/fl mice (0,91 vs 
0,08 a.u; * is p<0,05; n = 4 for each group (A); in-situ hybridization for Cox-2 showed only very few remaining Cox-
2+ cells (red; B); scale bar 500µm 
Figure 18: Genotyping gel for a representative litter of CAG+/iCre Cox2fl/fl mice; product for cre-recombinase at 286bp 
(A); genotyping for the floxed Cox-2 alleles with a band at 1058bp for the floxed and at 823bp for the wildtype allele 
(B); test for recombination after tamoxifen induction yielded a product with 651 bp, arrows mark mice with 
successful recombination (C); last two columns show positive and negative control for each pcr reaction. 
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3.3.1.2 Functional consequences of Cox-2 deletion in normally developed kidneys 
Analysis of the histological morphology of CAG+/iCre Cox2fl/fl mice showed none of the 
anomalies that are present in Cox-2 -/- mice61 (Figure 17). Under basal conditions these 
animals appeared healthy and had a normal kidney function (Figure 19).  
 
In Cox-2-/- mice a lower expression of renin has been reported under basal 
conditions52,87. This was not observed in the CAG+/iCre Cox2fl/fl mice where renin mRNA 
abundance and plasma renin concentration (PRC) was not significantly different from 
control mice (Figure 20) under basal conditions. 
Figure 19: Basal kidney function of CAG+/iCre Cox2fl/fl mice; the mice showed normal blood pressure (upper left; 
mean was 130,2 in CAG+/iCre Cox2fl/fl mice vs. 132,5mmHg in controls; n = 5), unchanged GFR (upper right; 874,1 
vs. 928,7µl/min/100gBW; n = 8); the urinary concentrating ability in these mice was normal (lower left; 1022,3 vs. 
939,5mOsmol/L); these mice showed a normal sodium excretion (lower right; 34,1 vs. 33,3mMol/L) 
  55 
 
If fed a low salt diet with the additional application of the ACE-inhibitor enalapril (LSE) 
for 10 days, control mice reacted with a heightened production and release of renin23. 
In mice with disrupted Cox-2 function in all cells of the kidney, however, a marked 
reduction in the recruitment of renin cells and decreased release of renin could be 
observed compared to control mice of the same treatment (Figure 20, Figure 21).  
 
In the reverse case, if these CAG+/iCre Cox2fl/fl mice were fed a high salt diet, the 
recruitment of Cox-2 in the medullary region of the kidney was absent. Blood pressure 
measurement in these mice, showed that mice with a Cox-2 deficiency in all cells had 
Figure 20: Renin expression and plasma concentration in CAG+/iCre Cox2fl/fl mice with a normal and low salt diet  
plus enalapril; under a basal conditions the CAG+/iCre Cox2fl/fl mice showed an unchanged renin mRNA abundance 
(1,16 vs.1,26a.u in controls; n = 4; left);  renin mRNA recruitment during low salt plus enalapril was significantly 
impaired in CAG+/iCre Cox2fl/fl mice (5,2 vs.10,4a.u in controls; n = 5;* is p< 0,05); plasma renin concentration was 
parallel to mRNA unchanged under basal conditions, but with an impeded recruitment under LSE (745,6 vs. 
2995,83ngANGI/ml*h-1 in control; n = 6) 
Figure 21: mRNA abundance of renin (green) visualized with RNAscope® on kidney sections of mice treated with a 
low salt diet and Enalapril for 10d; in wildtype mice large renin producing fields could be observed (A), these fields 
were absent in CAG+/iCre Cox2fl/fl mice (B); scale bar 500µm 
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a slightly higher rise in blood pressure but do not develop significant hypertension 
compared to their littermate controls (data not shown).   
 
3.3.2  Importance of Cox-2 in the FoxD1 compartment during nephrogenesis 
After identifying the medullary Cox-2 expressing cells as PDGFR-β+ interstitial 
fibroblast-like cells, I wanted to investigate their importance for kidney development.  
Interstitial fibroblast-like PDGFR-β+ cells derive from the FoxD1 compartment during 
nephrogenesis along with mesangial, vascular smooth muscle cells and renin 
producing cells11,107 (Figure 3). These cells are also strongly involved in the phenotype 
of Cox-2-/- mice.  
FoxD1 is expressed during nephrogenesis from embryonic day 11,5 on16. The 
expression of FoxD1 is limited to the embryonic phase and up to 3 days after birth in 
mice17. To evaluate the relevance of Cox-2 during this time and the immediate post-
natal period, I therefore generated FoxD1+/Cre Cox2fl/fl mice to delete Cox-2 already 
during nephrogenesis. 
Cox-2 was successfully deleted in the interstitial cells of the inner medulla, but Cox-2 
expression in the macula densa was conserved (Figure 22). 
FoxD1+/Cre Cox2fl/fl mice were born in mendelian ratios and both genders were fertile. 
Histological analysis of the FoxD1+/Cre Cox2fl/fl mice showed that the kidneys were 
developed normally. Glomeruli were distributed across the cortex and shaped 
normally, the subcapsular glomeruli found in Cox-2-/- mice were entirely absent (Figure 
23).  
Figure 22: In-situ hybridization for Cox-2 mRNA (brown signal) on a kidney section of a FoxD1+/Cre Cox2fl/fl mouse; 
Cox-2 mRNA signal is conserved in the cells of the macula densa (A and B); no Cox-2 signal could be detected in 
the kidney cortex outside of the macula densa (B); basal Cox-2 mRNA expression was absent in interstitial cells 
of the inner medulla (C); scale bar 20µm in A; scale bar 50µm in B and C 
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Animals with deletion of Cox-2 in stromal progenitors were normal in size and showed 
no abnormal kidney function (Figure 24). In all analyzed parameters, GFR, urine and 
sodium concentration as well as bodyweight no difference between FoxD1+/Cre Cox2fl/fl 
mice and their littermate controls could be measured.  
 
 
Figure 23: Whole kidney section of a Cox-2 -/- mouse, position of the glomeruli is marked in red (A); kidney section 
of a FoxD1+/Cre Cox2fl/fl mouse (B) showing a normal structure and normal distribution of glomeruli across the cortex 
and no subcapsular glomeruli; in addition to the subcapsular position of the glomeruli, Cox-2 -/- mice also showed a 
reduced number of glomeruli per section, this was not the case for FoxD1+/Cre Cox2fl/fl mice (C, n = 4); scale bar 
500µm 
Figure 24: FoxD1+/Cre Cox2fl/fl mice showed normal GFR (1316,6 vs. 1221,4µl/min/100gBW; upper left); normal 
weight (upper right); the ability to concentrate urine was unchanged (1812,8 vs. 1797,3mOsml/L in controls; lower 
left) and a normal sodium excretion (44,7 vs. 49,2mMol/L lower right) was measured; n ≥ 4 for each group 
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In these mice Cox-2 in macula densa cells was not deleted. Renin cell number and 
distribution was normal (Figure 25).  
 
qPCR measurement of Col1a1 mRNA in kidney tissue and Sirius red staining was 
performed to check for interstitial fibrosis seen in Cox2-/- mice61. Results did not show 
any pathological changes in adult FoxD1+/Cre Cox2fl/fl mice (Figure 26).  
 
 
Figure 25: Representative glomeruli (g) with immunohistochemical staining for α-SMA (blue) and renin (green) on 
a control (A) kidney section and the kidney section of a FoxD1+/Cre Cox2fl/fl mouse (B); no difference in the number 
or location of the renin cells could be observed, n = 4; scale bar 20µm 
Figure 26: Sirius red staining to visualize collagen deposits in the kidney tissue of an adult wildtype mouse (A) and 
an age matched FoxD1+/Cre Cox2fl/fl mouse (B); no difference in collagen disposition could be detected between 
groups; scale bar 500µm 
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3.3.2.1 Renin cell recruitment in FoxD1+/Cre Cox2fl/fl mice 
With the intact function of Cox-2 in cells of the macula densa (Figure 22) the 
recruitment of renin cells was unimpeded in FoxD1+/Cre Cox2fl/fl mice, when the RAAS 
was challenged. Plasma renin concentrations were unchanged under basal conditions 
and increased to similar levels when the mice were fed a low salt diet and treated with 
the ACE-Inhibitor enalapril (Figure 27) for 10 days. Renal renin mRNA levels also 
showed no difference between genotypes at any time.  
 
 
3.3.3 Function of Cox-2 in PDGFR-β+ interstitial medullary cells  
For the evaluation of the distinct function of Cox-2 in the medullary interstitial cells of 
the kidney, mice with a selective deletion of Cox-2 in only PDGFR-β+ cells were used 
(PDGFR-β+/iCre Cox2fl/fl mice). The function of Cox-2 in the macula densa of these mice 
was unchanged, allowing the attribution of any observed effects to the lack of medullary 
interstitial Cox-2 function.  
Deletion of Cox-2 was induced with a tamoxifen containing diet at an age of two month 
for four weeks and the mice were fed a normal diet for three weeks after the tamoxifen 
period before any experiments were performed. In-situ hybridization and quantification 
of the remaining Cox-2+ cells showed only few signals in the inner and outer medulla, 
but an unchanged expression in the macula densa cells of the cortex (Figure 28).  
Figure 27: Plasma renin concentration of FoxD1+/Cre Cox2fl/fl mice and littermate controls with a normal salt diet and 
with a low salt diet plus enalapril (LSE) in the drinking water; under normal conditions the plasma renin concentration 
was not different between FoxD1+/Cre Cox2fl/fl mice and their controls; when challenged with LSE both groups 
showed a strong increase in plasma renin concentration; n = 5 for each group 
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3.3.3.1 Functional relevance of interstitial Cox-2 expression under normal conditions 
After deletion of Cox-2 in interstitial PDGFR-β+ cells of adult mice, their basic kidney 
functions were evaluated to see whether the lack of Cox-2 in these cells produced a 
phenotype.  
Under basal conditions PDGFR-β+/iCre Cox2fl/fl mice showed no aberrations in their 
basic kidney functions. GFR in these mice was unchanged and no abnormalities in the 
urinary concentrating ability or the excretion of sodium and potassium could be 
measured (Figure 29).  
Figure 28: In-situ hybridization for Cox-2 on a kidney section of a wildtype (A) and a PDGFR-β+/iCre Cox2fl/fl mouse 
(B), Cox-2+ cells were emphasized in red; few cells expressing Cox-2 could be found in the inner medulla of PDGFR-
β+/iCre Cox2fl/fl mice, most were located in the cortex; quantitative analysis of Cox-2+ cells per kidney zone (C) showed 
a strong reduction in the number of cells in PDGFR-β+/iCre Cox2fl/fl mice in the inner medulla (40,6 vs. 321 cells in 
controls) and outer medulla (14,5 vs. 60,8 cells), while the cortical expression was unchanged (59,5 vs. 51,4 cells); 
n = 4; scale bar 500µm 
  61 
 
The deletion of Cox-2 in interstitial medullary PDGFR-β+ cells led to no persistent 
change in the mean arterial pressure. Furthermore, the excreted urine volume and 
correlating water intake, as measured over 24h in metabolic cages, was unchanged 
(Figure 33).  
On the level of mRNA abundance a significant reduction of medullary Cox-2 mRNA 
(Figure 30) was observed. Selected mRNA targets associated with salt and water 
handling in the inner medulla were measured. While a trend toward downregulation 
was conceivable for most targets, only the change in the sodium and chloride 
dependent betain/GABA transpoter 1 (BGT1) and Urea transporter A1 (UTA1) reached 
significance. Renin expression was unchanged in PDGFR-β+/iCre Cox2fl/fl mice. 
 
 
 
Figure 29: Basal kidney function of PDGFR-β+/iCre Cox2fl/fl mice with a normal salt diet; GFR was unchanged in 
these mice 4 weeks after Cox-2 deletion (929,7 vs. 950,4µl/min/100gBW in controls; upper left); in line the urinary 
osmolality (1590 vs. 1843 mOsmol/L; lower left) and sodium excretion (73,1 vs. 64,7mMol/L; lower right) were also 
unchanged, n ≥ 10; the PDGFR-β+/iCre Cox2fl/fl mice showed no persistent change in mean arterial blood pressure 
(136,1 vs. 132,2mmHg; n = 4; upper right) 
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3.3.3.2 Handling of high dietary sodium in mice deficient for Cox-2 in PDGFR-β+ cells 
After evaluating the basic kidney function of PDGFR-β+/iCre Cox2fl/fl mice, I wanted to 
investigate the ability of these mice to handle a high dietary sodium intake, as the 
recruitment of Cox-2 expression in this condition takes place only in medullary 
interstitial cells. 
Using in-situ hybridization I evaluated the recruitment pattern of Cox-2 after 14d high 
salt diet in PDGFR-β+/iCre Cox2fl/fl mice (Figure 31).  
Here only few additional cells could be recruited to express Cox-2 in the inner and 
outer medulla even under the high salt stimulus. 
Figure 30: mRNA abundance in the inner medulla of wildtype and PDGFR-β+/iCre Cox2fl/fl mice with a normal salt 
diet; expression of Cox-2 is significantly reduced in PDGFR-β+/iCre Cox2fl/fl mice along with UTA-1 and BGT1; other 
targets connected to osmolyte handling showed a trend to be downregulated but did not reach significance; n = 7 
for each group; * is p < 0,05 
  63 
 
In line with the in-situ hybridization results, only a slight increase in Cox-2 mRNA could 
be measured in the inner medulla of PDGFR-β+/iCre Cox2fl/fl mice compared to their 
littermate controls (Figure 32) when fed a high salt diet. 
 
For analysis of the kidney function in PDGFR-β+/iCre Cox2fl/fl mice, the high salt diet was 
fed for 14 days and then urine was collected, urine volume, water intake as well as 
GFR were measured (Figure 33).  
Figure 31: Recruitment of Cox-2 mRNA expressing cells (red signals) after a high salt diet in a wildtype mouse (A) 
and a PDGFR-β+/iCre Cox2fl/fl mouse (B); scale bar 500µm; number of Cox-2 expressing cells per kidney section 
and their zonal distribution in wildtype and PDGFR-β+/iCre Cox2fl/fl mice with a high salt diet (C; n = 4) 
Figure 32: Relative Cox-2 mRNA expression in the inner medulla of control mice or PDGFR-β+/iCre Cox2fl/fl mice on 
a normal salt diet (left pair) or a high salt diet (right pair); in control mice a clear induction of Cox-2 expression could 
be observed after 14d high salt diet, in the PDGFR-β+/iCre Cox2fl/fl mice this heightened Cox-2 expression was absent 
(n = 7 animals in each group); * is p < 0,05 
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Control mice fed a high salt diet showed a strong increase in urinary sodium excretion, 
GFR and urine volume when compared to a normal salt diet. In PDGFR-β+/iCre Cox2fl/fl 
mice the urinary concentration of sodium was significantly lower under the high salt 
diet than in control animals. To compensate this, the urine volume in PDGFR-β+/iCre 
Cox2fl/fl mice with high salt was increased to such a degree that the overall excretion 
of sodium was comparable to the control mice (601,8 in PDGFR-β+/iCre Cox2fl/fl vs. 
590,4µMol/24h sodium in controls). The increase in GFR observed in control mice was 
significantly lower in the mice without Cox-2 in PDGFR-β+ interstitial cells. In line with 
this, the PDGFR-β+/iCre Cox2fl/fl mice did not gain an inappropriate amount of weight 
during the treatment and showed no sign of edema or water retention. 
Figure 33: Changes in kidney function of control and PDGFR-β+/iCre Cox2fl/fl mice fed a normal salt diet or a high 
salt diet; in the mice lacking Cox-2 a significant increase in urine volume (1,97 vs. 1,59ml/24h in controls; p<0,05; 
n = 4; upper left) with a corresponding lowering of the urinary sodium concentration (305,5 vs. 371,3mMol/L; 
p<0,05; lower right) and  urine osmolality (1363 vs. 1680 mOsmol/L; p<0,05; lower left) was observed compared 
to control mice; in addition the increase in GFR that was observed in control mice was blunted in PDGFR-β+/iCre 
Cox2fl/fl mice (1118 vs. 1296µl/min/100gBW; p<0,05) 
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To gain a better understanding of the importance of Cox-2 in PDGFR-β+ interstitial 
cells for the regulation of blood pressure, the switch from a normal to a high salt diet 
was monitored by tail cuff measurement of arterial blood pressure. This allowed a direct 
observation of a rise in blood pressure in PDGFR-β+/iCre Cox2fl/fl mice and showed that 
this change was already significant within 48h after the start of a high salt diet and was 
persistent over several days (Mean of 142,3 vs 131,7mmHg in controls during high salt 
(Figure 34).  
 
To analyze the reason for the reduced concentrating ability in the kidney and 
permanently increased blood pressure in PDGFR-β+/iCre Cox2fl/fl mice a study of 
different transporters and channels in the inner medulla associated with salt handling 
was undertaken. Targets associated with Cox-2 were chosen to evaluate this 
maladaptation. The mRNA abundance for AQ2 and ENACα was unchanged between 
genotypes. Only UTA-1 and BGT1 showed a significantly reduced mRNA expression 
in PDGFR-β+/iCre Cox2fl/fl. Other osmolality-activated genes such as SMIT1, AR and 
HSP70.1 showed a downward trend, but failed to reach significance (Figure 35).  
Figure 34: Change in mean arterial blood pressure of wildtype and PDGFR-β+/iCre Cox2fl/fl mice, when switched from 
a normal salt to a high salt diet; the change in blood pressure was significant within 48h and persisted over several 
days in PDGFR-β+/iCre Cox2fl/fl mice while wildtype mice showed no significant increase in blood pressure (mean of 
142,3 vs 131,7mmHg in controls) in response to the heightened salt intake; n = 4 for each group 
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Figure 35: Selected mRNA targets in the inner medulla of control and PDGFR-β+/iCre Cox2fl/fl mice after 14d high 
salt diet, mRNA abundance for control mice on a normal salt diet was set as reference expression; as shown above 
no recruitment of Cox-2 took place in PDGFR-β+/iCre Cox2fl/fl mice; mRNA abundance was significantly lower for 
UTA-1 and BGT1 in PDGFR-β+/iCre Cox2fl/fl mice under a high salt diet; other targets did not reach statistical 
significance (n = 5 for each group); * is p < 0,05   
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3.4 Role of Cox-2 in kidney fibrosis  
3.4.1 Progression of adenine induced fibrosis in mice deficient for Cox-2 
The adenine-induced fibrosis model was chosen due to the inflammatory disease 
progression in this setting, as Cox-2 is a central player in inflammatory signaling. 
Furthermore interstitial cells have been shown to contribute greatly to the matrix 
expressing cells of this model99,108. Two stages of this fibrotic model were evaluated 
for the purpose of this study. The first being the acute fibrotic stimulus, after the mice 
had been fed a 0,2% adenine containing diet for three consecutive weeks (3wks). In 
the second approach, the mice were given three additional weeks for recovery from 
the adenine diet with a normal diet (3wks+3wks). At both time points, the remaining 
kidney function of the mice was evaluated by measuring their urinary concentrating 
ability, GFR and hematocrit under the treatment. mRNA abundance for key fibrotic 
targets was measured to check for differences in disease progression.  
 
Figure 36: Changes in kidney function during fibrosis induction with an adenine containing diet; between control 
and PDGFR-β+/iCre Cox2fl/fl mice no difference in the kidney function either directly after 3wks adenine diet or after 
an additional 3wks recovery period could be detected; the weight loss (upper right) was proportional in both groups; 
n = 6 for each group  
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Analysis of the remaining kidney function of PDGFR-β+/iCre Cox2fl/fl mice and their 
littermate controls after 3wks adenine diet showed no difference in the GFR (287,5 vs. 
255,5µl/min/100gBW in controls), urine concentrating ability (505,1 vs. 466,4 
mOsmol/L in controls) and sodium excretion (19,7 vs. 19,0 mMol/L in controls) (Figure 
36). Although PDGFR-β+/iCre Cox2fl/fl mice were lighter at the beginning of the 
experiment, their weight loss and gain in the recovery period ran parallel to the control 
animals. In the recovery period, after the mice were again fed a normal diet, no 
additional improvement in the kidney function of PDGFR-β+/iCre Cox2fl/fl mice could be 
observed. Hematocrit values were not significantly different between the experimental 
groups at any time point of this fibrotic model.  
 
Measurement of key fibrotic targets in PDGFR-β+/iCre Cox2fl/fl mice treated with an 
adenine diet showed a significant change from the control group only for Cox-2 (6,28 
vs. 10,32a.u in controls; p < 0,05) and Col1a1 mRNA (38,11 vs. 588,8a.u in controls, 
p < 0,05)  (Figure 37) after 3wks. Other targets such as α-SMA, Cx3CR1, Col3a1 and 
fibronectin were unchanged. To localize the residual Cox-2 mRNA expression in 
Figure 37: mRNA abundance measured before adenine diet, after 3 weeks of adenine feeding and with additional 
3 weeks recovery period for each target; a significant reduction could only be measured for Cox-2 and Col1a1; in 
all other targets no significant difference in mRNA abundance was observed; (n = 8, for each group in each 
condition)   
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PDGFR-β+/iCre Cox2fl/fl mice, I performed co-in-situ-hybridization for Cox-2 and several 
markers. On kidneys of control mice after 3wks adenine diet Cox-2 was detected in the 
normal expression sites of inner medullary interstitial cells, macula densa cells but also 
in dense cell clusters around small vessels in fibrotic lesions in the cortex. In PDGFR-
β+/iCre Cox2fl/fl mice the interstitial Cox-2 expression was absent. The Cox-2+ cells 
around the vessels did not co-express PDGFR-β or Cx3CR1 (Figure 38, top and 
middle).  
Only a small minority of the Col1a1 expressing cells also expressed Cox-2 (Figure 38, 
bottom). For tissue of mice that were fed a normal diet after the adenine diet, the 
expression pattern was the same but signal strength was weaker in accordance with 
the qPCR data.  
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Figure 38: Co-in-situ hybridization for Cox-2 mRNA (green) and different markers (red) on kidney sections of PDGFR-
β+/iCre Cox2fl/fl mice fed an adenine diet for 3 weeks; Cox-2 is expressed by probably infiltrating cells around vessels 
(dotted circles), these cells did not co-express PDGFR-β (red, top); the infiltrating Cox-2+ cells also did not express 
Cx3CR1 mRNA (red, middle); most of the Col1a1 mRNA expressing cells in fibrotic lesions also did not co-express 
Cox-2 (bottom); scale bar 20µm 
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3.4.2 Effects of Cox-2 deletion in PDGFR-β+ cells in the UUO model   
The second model used for the evaluation of the relevance of Cox-2 in PDGFR-β+ 
interstitial cells during kidney fibrosis was the unilateral ureter obstruction (UUO) for 5 
days. 
Macroscopic evaluation of the kidneys showed no difference in the degree of damage 
between control mice and PDGFR-β+/iCre Cox2fl/fl mice. 
 
The undamaged contralateral kidneys of PDGFR-β+/iCre Cox2fl/fl mice showed mRNA 
levels not different to those of controls, except for Cox-2. Comparing the mRNA 
abundance of key fibrotic targets between the UUO kidneys of control and PDGFR-
β+/iCre Cox2fl/fl mice, Cox-2 mRNA was significantly reduced. Difference in expression 
for the other measured targets such as α-SMA, Col1a1 and Cx3CR1 to evaluate the 
degree of fibrosis induced, did not reach significance (Figure 39). EPO mRNA was also 
not different for PDGFR-β+/iCre Cox2fl/fl mice compared to control mice. 
  
Figure 39: mRNA abundance for selected fibrotic targets in contralateral (CL) and UUO kidneys; only Cox-2 showed 
a significant reduction in the CL and UUO kidneys of PDGFR-β+/iCre Cox2fl/fl mice (upper left); for all other measured 
mRNAs no reduction in the fibrotic pathogenesis could be measured; n = 5 for each group, * is p< 0,05 between 
UUO; # is p<0,05 between CL 
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4 Discussion 
Of the two major isoforms of cyclooxygenase, Cox-1 has long been described as the 
constitutively expressed subtype, with a variety of important basal functions and Cox-
2 as the inducible form, without particular relevance under basal conditions4,23,58.  
With the widespread use of Cox-inhibitors to treat pain, acute inflammation and chronic 
inflammatory diseases such as arthritis, a number of side effects became apparent, 
limiting the usage of these drugs105,109,110. Since Cox-1 was believed to be the main 
housekeeping subtype, great hope was placed in the success of Cox-2 selective 
inhibitors. But unfortunately these selective drugs, had severe side effects of their own 
on the renal and cardiovascular system48,74,105,111,112.  
It became clear that Cox-2 must have important functions for the salt and water balance 
of the body and blood pressure homeostasis48,53,105. After the connection between 
selective Cox-2 inhibition and the salt sensitivity of some hypertensive patients became 
known, the kidney was investigated more closely48,53,77,113.  
Two expression sites for Cox-2 often have been described in the kidney. One being 
the cells of the macula densa in the cTAL, where Cox-2 derived prostaglandins 
influence the renin production and secretion according to the luminal sodium 
concentration of the urine4,7,23,34. The second expression site for Cox-2 has mostly 
been referred to as “medullary Cox-2 expressing interstitial cells” up to this date23,46. 
No structured investigation into the exact location, regulation, nature and properties of 
these medullary Cox-2+ cells has been undertaken to my knowledge.  
Not much is known about the developmental origin of Cox-2 expressing cells despite 
the important role of Cox-2 during nephrogenesis49,81,82. Furthermore it is unclear 
whether these cells are a homogenous population or if different cell types, such as 
collecting duct cells53,77,77 as well as interstitial cells23,46,53 are able to express Cox-2 
under different conditions. The inducibility of medullary Cox-2 expression has been 
repeatedly reported23,74,80 but it remains unclear in which cells exactly this upregulation 
of Cox-2 takes place. This lack of knowledge until now is most likely due to the lack of 
a robust detection technique, to reliably locate Cox-2 in cells of the inner medulla. The 
missing localization of Cox-2 in the inner medulla also leads to the lack of an adequate 
mouse model for the isolated investigation into the medullary function of Cox-2. 
In this study I used the novel RNAscope® technique to reliably localize Cox-2 in cells 
of the inner medulla of mice and characterize these cells concerning their 
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developmental path and co-expression of other cellular markers. The further aim of 
this study was to investigate the function of medullary Cox-2 expression under basal 
conditions, a high salt stimulus and in the event of kidney fibrosis with a selective 
deletion of Cox-2 only in the medullary interstitial cells.  
 
4.1 Cox-2 expression and regulation in cells of the kidney 
Over the years, many different cell types have been reported to express Cox-2 in the 
kidney. The expression of TNC in Cox-2+ cells of the medulla has been reported104,114 
as well as the presence of Cox-2 in cells of the collecting duct53,80,105. But no convincing 
prove for or against either has been published to date. 
The RNAscope® in-situ hybridization technique makes it possible to visualize not only 
one mRNA target, but also a second different mRNA on the same tissue. This allows 
the definite co-localization of Cox-2 mRNA with other cellular markers for a closer 
characterization of Cox-2+ cells.  
Cox-2 mRNA expressing cells in the kidney cortex of mice are localized in the 
characteristic position of macula densa cells close to the vascular pole of glomeruli 
(Figure 6). No other cells showed a positive signal for Cox-2 mRNA in the cortex. 
Evaluation of the basal expression pattern in the inner and outer medulla of the murine 
kidney showed that only interstitial cells stained positive for Cox-2 mRNA (Figure 6). 
In accordance with previous findings46, the Cox-2 expression was restricted to the inner 
medulla and the inner stripe of the outer medulla. To verify that the Cox-2 signal was 
localized in interstitial fibroblast-like cells, a co-hybridization with the interstitial marker 
PDGFR-β was performed. This dual detection of Cox-2 and PDGFR-β also allowed a 
quantification of the Cox-2/PDGFR-β expressing cells. Nearly all Cox-2 expressing 
cells in the medulla also express PDGFR-β (Figure 7), and can be classified as 
interstitial fibroblast-like cells, with their characteristic shape of a small cell body with 
long processes. The near complete overlap of PDGFR-β and TNC in these cells further 
supports this characterization (Figure 8). CD73, which is another prominent marker for 
interstitial cells did not co-localize with Cox-2 due to the different zonal expression. 
Only PDGFR-β+ cells from the outer stripe of the outer medulla and the cortex co-
express CD73, and there no Cox-2 mRNA was detected17. 
Contrary to other groups53,80,105, I could not detect any Cox-2 mRNA in collecting duct 
cells, or other non-interstitial cells of the medulla. This contradiction to the multiply 
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reported presence of Cox-2 in CD cells might on the one hand be due to a differential 
expression between species, the system used for detection and the experimental 
setup. With isolated tubules or isolated and cultivated cells an artificial induction of 
Cox-2 due to the isolation and culture conditions cannot be excluded as Cox-2 is also 
a major component of the stress reactions in cells83,115,116. Co-expression of the two 
Cox isoforms could only be detected in the medullary interstitial cells (Figure 9). Macula 
densa cells did not show any Cox-1 expression while the collecting ducts showed a 
very robust signal for Cox-1 (Figure 40).   
 
To address the question what cells in the inner and outer medulla are able to express 
Cox-2 in a stimulated setting, I performed in-situ hybridization on tissue of mice either 
fed a high salt (4%) diet or deprived of water (Figure 12). Both conditions have 
previously been reported to show a marked increase in the medullary PGE2 expression 
(Figure 13)4,24,30,37,48. Even under stimulated conditions, high salt treatment showing 
the strongest recruitment of Cox-2+ cells, Cox-2 mRNA was strictly confined to 
PDGFR-β and TNC positive interstitial cells (Figure 14). In the cortex, no Cox-2 mRNA 
could be detected outside the macula densa cells under these conditions. As under 
basal conditions, CD cells and other tubular compartments were free of Cox-2 
expression. 
Figure 40: Overview of the expression sites for Cox-1 and Cox-2 along the nephron in the kidney; Cox-1 is 
expressed in the glomerulus, collecting ducts and the interstitial cells of the medulla; Cox-2 expression is strictly 
confined to the cells of the macula densa and the interstitial cells of the medulla in all conditions studied for this 
work 
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Hypoxia-signaling is another postulated regulator of medullary Cox-2 expression55,117. 
I used mice with the genetic deletion of Vhl to stabilize the hypoxia inducible factors 
selectively in PDGFR-β+ interstitial cells (PDGFR-β+/iCre Vhlfl/fl mice )1,14. Stabilization 
of HIF induces permanent activation of hypoxic signaling in these cells. In accordance 
with previous findings53,55,56 the induction of hypoxia signaling led to an upregulated 
Cox-2 expression (Figure 15) compared to wildtype mice. Induction of Cox-2 
expression by the hypoxic signaling pathway via HIF might be a protective mechanism 
designed to improve renal blood flow through the vasodilating actions of PGE2 under 
physiological conditions. The additionally recruited Cox-2+ cells were again exclusively 
interstitial PDGFR-β+ cells located in the inner medulla and the inner stripe of the outer 
medulla, although HIF signaling was induced in all interstitial cells of PDGFR-β+/iCre 
Vhlfl/fl mice. Another effect of the HIF stabilization in PDGFR-β+ interstitial cells is the 
strong induction of EPO expression in nearly all of these cells1. The recruited EPO 
producing cells are distributed over all kidney zones, and the question arose whether 
the medullary PDGFR-β+ interstitial cells could produce EPO and Cox-2 at the same 
time. The interstitial cells of the cortex showed only a strong signal for EPO mRNA but 
no Cox-2 expression (Figure 13, D, Figure 16), in the inner stripe of the outer medulla 
a large number of Cox-2 expressing cells also expressed EPO.  
In principal some Cox-2+ cells of the inner and most in the outer medulla are able to 
produce EPO at the same time, while PDGFR-β+ cells in the cortex can produce EPO, 
but are inhibited from expressing Cox-2 by a yet undefined mechanism.  
From these findings I conclude that the cells of the medulla capable of expressing Cox-
2 under basal conditions in the adult kidney, are interstitial PDGFR-β and TNC positive 
fibroblast-like cells. These cells are the only medullary cells to express Cox-2 even 
under stimulated conditions and thus represent a functional subpopulation of the large 
pool of PDGFR-β+ interstitial cells distributed across the whole kidney (Figure 40).  
Comparison of these results in mice with the often used rat kidney46,74,77 showed a 
much higher and also different expression of Cox-2 under basal conditions (Figure 11). 
Rat tissue expressed Cox-2 in glomeruli along with a much stronger medullary 
expression. The collecting ducts of the rats showed no Cox-2 expression. This much 
stronger expression of Cox-2 in rat kidneys might be the reason for different results 
concerning the function of Cox-2 reported between different laboratory species.  
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4.2 Different functions of Cox-2 in the kidney  
4.2.1 Cox-2 in the adult kidney  
The models most used to study Cox-2 expression have been either rat kidneys or 
cultivated cells to date. The rat poses a significantly biased model, as the Cox-2 
expression in this species is much higher than in mice and humans (Figure 11)43. 
Cultured cells lack in vivo cell-cell interactions that might be relevant for the 
physiological regulation of gene expression and function. The generation of a complete 
Cox-2 knockout mouse81 moved the investigative focus into a species with greater 
similarities to humans, but it had serious problems. The Cox-2-/- mice showed a severe 
developmental phenotype in the kidney (Figure 23, A) and other systemic effects61,81. 
While this showed the importance of Cox-2 during nephrogenesis, other findings in 
adult Cox-2-/- mice are potentially influenced by these defects and cannot solely be 
attributed to the lack of Cox-252,87.  
A new model for the cell specific deletion of the Cox-2 gene with the Cre/loxP system 
has been generated88. The investigators inserted loxP sites into the Cox-2 gene, 
resulting in a stop-codon in exon 6 of the Cox-2 gene after recombination. I used this 
model to investigate the function of Cox-2 in normally developed adult kidneys 
(CAG+/iCre Cox2fl/fl mice). This experimental approach had the advantage of excluding 
any potential developmental effects81,87,118, since the deletion of the Cox-2 gene was 
induced after the mice reached adulthood. It also gave insight into the efficiency of the 
Cox-2 deletion with the Cre/loxP system. All experiments were conducted with mice of 
a C57BL/6 background. In previously published data this strain showed no 
hypertension under basal conditions and the least severe phenotype61. This 
background was chosen to exclude as many outside factors as possible, such as an 
androgen-influenced component with effect on the renin system61,119.  
The CAG+/iCre Cox2fl/fl mice showed no morphological or functional anomalies after the 
deletion was induced with a tamoxifen containing diet (Figure 19). In-situ hybridization, 
genotyping and mRNA analysis verified the deletion of Cox-2 for nearly all cells (Figure 
17). Some investigators found a lower expression of renin52,87 under basal conditions 
in Cox-2-/- mice, while others reported no change in the renal renin expression119. The 
basal renin expression in CAG+/iCre Cox2fl/fl mice was unchanged compared to their 
littermate controls (Figure 20). This is most likely due to the intact glomerular structure 
in the mice used for this study. Previous studies showed, that the malformation of 
subcapsular sclerotic glomeruli in Cox-2-/- mice and the varying severity of the renal 
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phenotype, depending on the background of the mice, are possible reasons for the 
contradicting published data10,61,87. This taken together with the functional data (Figure 
19) led me to the conclusion that Cox-2 expression in the normally developed kidney 
is not essential for basic kidney function and blood pressure homeostasis under normal 
conditions in this experimental model. The normal blood pressure in CAG+/iCre Cox2fl/fl 
mice after deletion of Cox-2 in all kidney cells is congruent with findings in previous 
studies46,61.  
Under stress conditions that activate the RAAS, a low salt diet with application of the 
ACE-Inhibitor enalapril, the CAG+/iCre Cox2fl/fl mice showed a significantly reduced 
amount of renal renin mRNA. This strongly reduced recruitment of renin producing 
cells and the lower PRC in CAG+/iCre Cox2fl/fl mice on LSE treatment is in accordance 
with previous findings (Figure 20, Figure 21)43,52,87,119. The degree to which Cox-2 
influences renin release has been discussed controversially in the past10,43,61. Low 
renal perfusion, the activation of the sympathetic nervous system and blood pressure 
changes have also been postulated to stimulate renin release6,10. On the other hand a 
direct feedback of ANG II via AT1 receptors on renin producing cells has recently been 
disproven120. Due to the normally developed kidneys in CAG+/iCre Cox2fl/fl mice I was 
able to show that the basal expression of renin is unaffected by a loss of Cox-2 function 
in all kidney cells, but the renin mRNA recruitment in response to RAAS challenge is 
greatly dependent on Cox-2 expression in this model. When applying the opposite salt 
treatment, of 4% sodium, to these mice blood pressure measurement yielded similar 
results as previously reported in rats46,61. There only a medullary infusion of a selective 
Cox-2 inhibitor led to hypertension, but the systemic application resulted in no change 
in blood pressure.  
 
4.2.2 Role of Cox-2 in the stromal progenitor compartment  
As stated in the introduction, the global deletion of Cox-2 during nephrogenesis leads 
to a severe renal phenotype. The renal phenotype in Cox-2-/- mice presents with 
subcapsular, sclerotic glomeruli, interstitial fibrosis at an early age, shortening of the 
arterial tree and lower renin expression as described above61,81,87. In addition it also 
causes an increased neonatal mortality, shortened lifespan and female sterility61,81. To 
date all investigations into the role of Cox-2 during nephrogenesis were conducted with 
a systemic approach through global deletion of the Cox-2 gene or application of Cox-
2 inhibitors at different time points.  
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The majority of cells affected by the renal phenotype in Cox-2-/- mice, are interstitial 
cells, mesangial and vascular cells, all deriving from the FoxD1+ compartment of 
stromal progenitors during nephrogenesis (Figure 3). For a more specific investigation 
of the involvement of Cox-2 in this compartment during the embryonic phase and 
immediate postnatal phase, I generated FoxD1+/Cre Cox2fl/fl mice to study their kidney 
development and function.  
In these mice the normal interstitial expression of Cox-2 in the renal medulla is absent, 
but expression of Cox-2 in cells of the macula densa is unaffected when evaluated by 
zonal mRNA analysis and in-situ hybridization (Figure 22). This selective deletion 
proves a different developmental path for the two Cox-2 expressing compartments in 
the kidney. FoxD1+/Cre Cox2fl/fl mice were born in mendelian ratios and both genders 
were fertile unlike the Cox-2-/- mice81. No increased rate of neonatal mortality was 
observed and basal kidney function and weight of adult FoxD1+/Cre Cox2fl/fl mice was 
normal (Figure 24). Histological analysis of mature FoxD1+/Cre Cox2fl/fl kidneys showed 
that the anomalies seen in Cox-2-/- mice were entirely absent. The FoxD1+/Cre Cox2fl/fl 
mice showed a normal number of glomeruli, none in a subcapsular position (Figure 23) 
and normal renin expression (Figure 25). Furthermore, the interstitial fibrosis reported 
for Cox-2-/- mice61,81 was absent in FoxD1+/Cre Cox2fl/fl mice, pointing to a normal 
function of renal interstitial fibroblast-like cells even in the absence of Cox-2 (Figure 
26) during development. 
With this cell specific approach, I could exclude Cox-2 expression in the FoxD1+ 
stromal progenitor compartment as an essential factor for normal kidney development 
and the post-natal developmental phase in mice. This is in good agreement with recent 
findings by another group49,82. The authors postulate the Cox-2 dependent renin-
angiotensin system activation in the immediate postnatal phase as crucial for normal 
kidney development. This signaling pathway is conserved in FoxD1+/Cre Cox2fl/fl mice 
as the macula densa expression of Cox-2 is unaffected by this model. Interestingly, 
the salt reabsorption in the immediate postnatal period that has been described as a 
factor for the normal glomerular development82 seems to be independent of Cox-2 
signaling in the inner medulla during this developmental stage. Furthermore, while the 
salt supplementation experiment by Slattery et. al82 was able to alleviate in part the 
glomerular malformations caused by the deletion in Cox-2-/- mice, a stunted cortical 
growth, resulting in thin cortical tissue in adult mice remained. Therefore, the authors 
speculate that there might be a second pathway for Cox-2, independent of the 
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activation of the RAAS and AT1 receptors, to influence postnatal kidney development. 
The normally developed cortex of FoxD1+/Cre Cox2fl/fl mice (Figure 23) points toward 
either the tubular segments as focal points for the postnatal kidney development or 
extra-renal factors. The theory of a possible tubular involvement is further supported 
by combining the findings of Slattery et. al82, namely the partial phenotype rescue of 
Cox-2-/- mice with a AT1 receptor agonist, with recent findings in our laboratory. We 
could show that AT1 receptors in the FoxD1+ compartment are not essential for normal 
kidney development121. These findings taken together show that further investigation 
into the exact localization of RAAS activity during the postnatal kidney development is 
necessary.  
In line with the normally developed kidneys of FoxD1+/Cre Cox2fl/fl mice, no anomalies 
in their basic functions such as GFR, urinary concentration and blood pressure 
regulation could be detected. The normal sodium excretion of these animals allows the 
hypothesis that the missing medullary Cox-2 expression can be compensated under 
normal conditions. Recruitment of renin producing cells during LSE treatment was also 
not changed in FoxD1+/Cre Cox2fl/fl mice. These data identifies the macula densa 
expression of Cox-2 as the expression site responsible for the results obtained with 
CAG+/iCre Cox2fl/fl mice under LSE and is in good accordance with pervious studies4,6,10  
 
4.2.3 Function of medullary Cox-2 expression with different dietary sodium intake  
The salt sensitivity of many hypertensive patients is a growing and badly understood 
problem, especially with the salt loaded diet in industrialized countries. Dietary salt 
intake has been shown to exacerbate an already existing hypertension and induce 
formerly normotensive individuals to develop a de novo hypertension with the manifold 
cardiovascular risks involved73,113.  
To investigate the function of medullary Cox-2 expression in the setting of a salt 
challenge I chose a mouse model to mimic the human circumstances as closely as 
possible. 
PDGFR-β+/iCre Cox2fl/fl mice develop normally with fully functioning Cox-2 expression 
in all cells, until Cre-recombinase activity is induced with a tamoxifen containing diet. 
PDGFR-β+/iCre Cox2fl/fl mice express Cox-2 normally except in the interstitial fibroblast- 
like cells of the inner medulla after recombination. The cells of the macula densa are 
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unaffected by this model (Figure 6). This is a model allowing the investigation of only 
medullary Cox-2 function and excluding developmental defects. 
On the mRNA level, a strong reduction in medullary Cox-2 could be observed indicating 
a successfully induced deletion of Cox-2 (Figure 28). Congruent with the results from 
FoxD1+/Cre Cox2fl/fl mice, the PDGFR-β+/iCre Cox2fl/fl mice showed no morphological or 
functional anomalies under basal conditions with a balanced salt diet including sodium 
excretion and blood pressure homeostasis (Figure 29).  
While most Cox-2 associated mRNA targets showed a trend toward downregulation, 
only BGT1 and UTA-1 reached significance (Figure 30). This is similar to results in 
Cox-2-/- mice, these also showed that BGT1 is strongly controlled by Cox-2 activity, 
while other small osmolyte transporters, aldose reductase (AR) and sodium dependent 
myo-inositol cotransporter (SMIT1) seem to have secondary regulators besides Cox-
224. These results fit with the observations in humans, that kidney damage through 
selective Cox-2 inhibitors often requires additional risk factors67. 
It was the aim of this part of my study to investigate what effects the medullary Cox-2 
deletion had on kidney function when the animals were challenged by a high dietary 
sodium intake.  
PDGFR-β+/iCre Cox2fl/fl mice treated with a high salt diet showed a rapid and sustained 
rise in blood pressure (Figure 34). Sodium excretion and GFR increase in these mice 
was impeded and compensated with a rise in urine volume when compared to the 
control animals (Figure 33). This lower urinary sodium concentration connects well with 
a study by Chen et. al30 that showed PGE2, when infused medullary, promotes sodium 
excretion. It is conceivable that through deletion of Cox-2 in the medulla of PDGFR-
β+/iCre Cox2fl/fl mice, a lower PGE2 availability leads to the lower sodium concentration 
in the urine on a high salt diet. In-situ hybridization showed that only few additional 
Cox-2 expressing cells could be recruited in PDGFR-β+/iCre Cox2fl/fl mice during the high 
salt diet. Taken together with the lack of increased Cox-2 mRNA abundance, I 
conclude that PDGFR-β+ interstitial cells of the inner medulla are the only cell 
population in the kidney capable of expressing Cox-2, besides the cells of the macula 
densa. No other cells can be recruited to compensate the missing Cox-2 expression. 
Analysis of the zonal mRNA abundance in these mice showed that no compensatory 
rise in Cox-1 expression took place (data not shown), indicating a specific non-
interchangeable function for medullary Cox-2 expression. The strong reduction in 
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medullary BGT1 mRNA abundance is in good accordance with previous works (Figure 
35)24. AR and SMIT1 on the other hand seem to have secondary regulatory 
mechanisms and are not significantly affected by the lack of medullary Cox-2 
expression51,77, this is in good accordance with the data of this work.  
The persistent rise in blood pressure of PDGFR-β+/iCre Cox2fl/fl mice led me to question 
the possible mechanism for this change. Very recently, other investigators have also 
described elevated blood pressure in mice lacking Cox-2 in medullary cells on a high 
salt diet104. In this study, the authors hypothesized that a rise in medullary AQ2 and 
ENACα mRNA abundance leads to a volume challenge and subsequent rise in blood 
pressure for these mice.  
My data could not confirm these findings, as the mRNA abundance for AQ2 and 
ENACα showed no significant changes when compared to the control mice (Figure 
35). The mice in the study by Zhang et. al104 showed a much slower increase in blood 
pressure, reaching significance only after 4 weeks, than it was observed in the mice of 
this study (Figure 34). The above mentioned study and others have also postulated an 
important role for Cox-2 expression in the survival of medullary cells under 
stress24,51,104. In PDGFR-β+/iCre Cox2fl/fl mice no pathological changes or necrotic 
lesions could be detected even after maintaining the high salt diet for a prolonged time 
(data not shown). A possible explanation for these different results is the much higher 
concentration of sodium (8%) fed in the study by Zhang et. al104 compared to the 4% 
sodium in the high salt diet used for this study. To sum up the lower salt concentration 
and the not significantly changed mRNA expressions for AQ2, ENACα and two of the 
three investigated osmolyte transporters might explain the intact kidney tissue in 
PDGFR-β+/iCre Cox2fl/fl mice.  
Taking together the intact kidney structure, lack of sodium and water retention, the 
unchanged levels for AQ2 and other targets in the PDGFR-β+/iCre Cox2fl/fl mice, the lack 
of medullary prostaglandins balancing the action of ANGII might be the reason for the 
blood pressure rise in this model. The vasoconstrictive effects of ANGII have 
previously been reported to play an important role in Cox-2 inhibitor mediated 
hypertension and reduced renal blood flow4,45,74,84,122. The hypothesis of renal ANGII 
vasoconstriction is supported by considering further points. On the one hand when 
comparing this study with data of a study by Yu et. al64, their results could not be 
confirmed. Yu et. al postulated that the salt sensitivity under Cox-2 selective inhibitors 
was attributed to a lack of Cox-2 derived prostaglandins in the aorta. In-situ 
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hybridization for Cox-2 and PDGFR-β was performed on aortae of wildtype mice with 
a normal and high salt diet to exclude this possibility. In both cases the presence of 
PDGFR-β mRNA could be confirmed, but no signal for Cox-2 mRNA was observed 
(data not shown). Another point arguing against a systemic effect of Cox-2 as the 
reason for the hypertension is the short stability of PGE235. It seems unlikely that the 
medullary Cox-2 products would exert their main function outside the kidney in such a 
short time. In the review of Cowley, Jr.84 an increased responsiveness to ANGII of rats 
pretreated with Cox-2 inhibitors was discussed, along with the possible influence of 
medullary pericytes on renal blood flow. The renal pericytes are targeted by the 
deletion of Cox-2 in this study and might thus be in part responsible for the observed 
hypertension.  
Taking these points together, I can conclude that Cox-2 expression in PDGFR-β+ 
interstitial fibroblast-like cells is essential for renal blood pressure homeostasis under 
a high sodium challenge. This study was focused on identifying, localizing and 
characterizing the cells in the inner medulla expressing Cox-2 and the functional 
consequences of a targeted deletion. But the elucidation of the one or possibly different 
mechanisms following Cox-2 deletion and contributing to the salt sensitive 
hypertension needs further investigation.  
 
4.5 Cox-2 in two models of kidney fibrosis 
Many different models to mimic the human pathology of kidney fibrosis have been 
established over the years98,99,108. In this work two mechanistically different models 
have been chosen to evaluate the involvement of Cox-2 in resident PDGFR-β+ 
interstitial fibroblast-like cells of the kidney in the pathological disease progression.  
 
4.5.1 Influence of Cox-2 deletion in PDGFR-β+ cells on adenine-induced nephropathy 
The model of adenine induced nephropathy is characterized by considerable interstitial 
inflammation and fibrosis, tubular atrophy and cardiovascular effects that closely mirror 
the symptoms seen in human patients with CKD99,100,108. Cox-2 has been described as 
a major player in the inflammatory pathway68,72,123.  The adenine-induced fibrosis was 
chosen due to the contribution of interstitial inflammation and fibrosis in the phenotype 
of this model. It was the aim of this experimental setup to determine whether the lack 
of Cox-2 in PDGFR-β+ interstitial cells in this model had any effect on the progression 
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of kidney damage inflicted by adenine feeding or if it changed the recovery of mice 
after they returned to a normal diet. 
Evaluation of GFR and kidney function showed neither adverse nor protective effects 
for a lack of Cox-2 in PDGFR-β+ interstitial fibroblast-like cells. PDGFR-β+/iCre Cox2fl/fl 
mice showed the same decrease and recovery of the analyzed kidney parameters as 
their littermate controls over the entire experiment (Figure 36). Concerning the anemia 
caused by the loss of EPO production in the kidneys observed in this model and human 
CKD patients, the deletion of Cox-2 had no effect on hematocrit values after 3 weeks 
(3wks) of the adenine diet or after additional 3 weeks recovery.  
On the mRNA level the increase of Cox-2 mRNA was significantly lower in PDGFR-
β+/iCre Cox2fl/fl mice after 3 weeks adenine than in control mice. These data signify that 
the PDGFR-β+ interstitial fibroblast-like cells contribute to the proinflammatory reaction 
after 3wks adenine, but are not the only cell type expressing Cox-2 under these 
conditions. In-situ hybridization located the residual Cox-2 expression in non PDGFR-
β+ cells grouped around small vessels in fibrotic lesions of the kidney cortex after 3wks 
adenine (Figure 38, top). As these do not express PDGFR-β and are localized so 
strikingly in dense clusters around vessels, they are most likely not resident fibroblast-
like cells of the kidney, but infiltrating cells. To gain more information about these 
infiltrating cells co-localization of Cox-2 with Cx3CR1 was performed. Cx3CR1 is a 
chemokine receptor associated with leukocyte migration and adhesion124,125. However 
there was no overlap between Cx3CR1 and Cox-2 mRNA, but Cx3CR1 positive cells 
were clustered around the Cox-2 expressing cells (Figure 28, middle). The mRNA 
abundance of Col1a1 was also reduced in PDGFR-β+/iCre Cox2fl/fl mice after 3wks 
adenine and Col1a1 expressing cells were clustered in a pattern similar to Cx3CR1 
around the infiltrating Cox-2 expressing cells (Figure 38, bottom). Recent studies 
showed that a large percentage of the Col1a1 production in adenine-induced fibrosis 
stems from hematopoietic cells, these cells are mostly responsible for the residual 
Col1a1 expression100. This and the unchanged abundance of other markers explains 
the lack of functional improvement in the PDGFR-β+/iCre Cox2fl/fl mice. The mRNA 
results of PDGFR-β+/iCre Cox2fl/fl mice might also show that there are different pathways 
inducing the expression of the classical fibrosis markers Col1a1 and α-SMA in the 
acute phase, as the abundance of α-SMA was unchanged. This detailed mechanism 
of differential induction between different fibrosis markers needs further investigation. 
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Cox-2 expression in resident PDGFR-β+ interstitial fibroblast-like cells might play a 
small role in the inflammatory response of the kidney in the model of adenine-induced 
nephropathy, but it is not a focal point for the disease progression. Local Cox-2 
expression seems to be only one component inducing the expression of fibrotic 
markers. The localization of infiltrating Cox-2+ cells with pro-fibrotic cells grouped 
around them gives rise to the idea that these cells play a role in cell migration and 
transformation during fibrosis and are not resident kidney cells.  
 
4.5.2 Role of Cox-2 in PDGFR-β+ interstitial cells during 5d UUO 
The second model I chose for the investigation of Cox-2 in resident PDGFR-β+ 
interstitial cells during fibrosis was the unilateral ureter obstruction (UUO). In this 
model, one ureter is surgically ligated and the resulting pressure and urine backflow 
induces fibrotic changes in the kidney tissue. Compared to the model of adenine-
induced nephropathy the progression is much more rapid, with greater structural 
damage to the ligated kidney. But with the UUO model, only one kidney is affected, 
while the other remains functional126. In this study a medium duration of 5 days for 
UUO was chosen. Previous studies have reported a beneficial role for Cox-2 in the 
UUO model and a more severe progression if Cox-2 is inhibited90,127. Others have 
reported a more controversial role for Cox-2 depending on the mode of inhibition91,92.  
In PDGFR-β+/iCre Cox2fl/fl mice no effect on the progression of the UUO induced 
damage could be observed. Histological analysis showed no difference in the damage 
by 5d UUO between Cox-2 deficient mice and their controls. In line with this, the mRNA 
abundance for key fibrotic markers Col1a1, α-SMA and Cx3CR1 were unchanged in 
the UUO kidneys when compared to the UUO kidneys of control animals. The mRNA 
abundance for Cox-2 was again significantly lower in PDGFR-β+/iCre Cox2fl/fl mice. 
Comparable mRNA levels for Col1a1 in both groups might be an indication that 
different pathways for the Col1a1 induction are active in different fibrotic models.  
The unchanged progression of the fibrotic changes in the UUO kidneys of PDGFR-
β+/iCre Cox2fl/fl mice contradicts with the above mentioned studies90,127, postulating a 
protective role for Cox-2 during UUO. These different results are most likely due to 
major differences in the experimental approach. In the mentioned studies, the 
investigators used either the Cox-2-/- mice with their inherent histological and functional 
deficiencies or a pharmacological inhibition of Cox-2 affecting a systemic block of all 
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Cox-2 activity. I used a cell specific approach for the first time to my knowledge with 
the targeted deletion of Cox-2. I could show that the protective effect of Cox-2 seen in 
other studies must be exerted by a source outside the normal interstitial Cox-2 
expressing cells in the kidney. A most likely hypothesis would be the overall reduction 
in proinflammatory stimuli achieved by global Cox-2 deletion or pharmacological 
inhibition.  
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5 Summary 
Cyclooxygenase 2 is a key enzyme in the production of prostaglandins. The 
widespread application of Cox-2 selective inhibitors to treat pain and inflammation has 
shown severe renal side effects for these drugs. But the exact expression sites for 
Cox-2 and its normal function in the kidney is not yet clear.  
Utilizing a novel in-situ hybridization technique Cox-2 could be distinctly located in two 
developmentally different cell populations of the murine kidney. In the cortex only 
specialized macula densa cells of the cTAL express Cox-2. In the renal medulla, 
interstitial fibroblast-like cells, characterized by the expression of PDGFR-β and TNC, 
produce Cox-2 mRNA.  
Stimulating Cox-2 expression in the kidneys of mice, through a high dietary sodium 
intake, Cox-2 expression was induced only in the inner medulla and the inner stripe of 
the outer medulla. This recruitment of Cox-2 expressing cells only took place in 
interstitial PDGFR-β+/TNC+ cells. In mice deprived of water for 24h the recruitment 
pattern and cell type was the same, but the total number of Cox-2 expressing cells was 
on average lower than in high salt treated mice. The model of genetic stabilization of 
the HIF pathway in PDGFR-β+/iCre Vhlfl/fl mice not only showed that Cox-2 is a hypoxia 
inducible gene, but that an overlap between Cox-2 and EPO expression in the same 
cell is possible. The locally very restricted inducible expression of medullary interstitial 
Cox-2 led me to classify these cells as a functional subpopulation of the large pool of 
PDGFR-β+ interstitial cells. No Cox-2 expression could be detected in non-interstitial 
cells or in interstitial cells of the cortex in the conditions investigated in the scope of 
this work. 
The medullary Cox-2+ cells, as well as most cells involved in the severe phenotype of 
global Cox-2 deficient mice, namely mesangial cells and vascular smooth muscle cells 
derive from the FoxD1+ stromal progenitor compartment. The role of Cox-2 during 
nephrogenesis was evaluated with a selective deletion in this compartment with 
FoxD1+/Cre Cox2fl/fl mice. The mice with a targeted Cox-2 deletion in the stromal 
compartment, but intact Cox-2 function in the cells of the macula densa, showed no 
developmental or functional defects. In FoxD1+/Cre Cox2fl/fl mice the recruitment of renin 
on a low salt stimulus was normal unlike in the mice with a total deletion of Cox-2.  
In adult mice, the strong medullary induction of Cox-2 with a high dietary sodium intake 
implicates a functional connection between Cox-2 and the salt handling capability of 
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the kidney. The lack of an adequate model made the distinction between the functions 
of the different Cox-2 expression sites difficult. With the use of PDGFR-β+/iCre Cox2fl/fl 
mice, it was possible to study the functional consequences of the isolated deletion of 
Cox-2 only in medullary interstitial cells under different conditions. This model showed 
that missing Cox-2 expression in the renal medulla led to reduced concentrating ability 
for sodium with a compensatory rise in urine volume and persistent hypertension under 
a high salt diet.  
Experiments performed, concerning the role of Cox-2 in PDGFR-β+ cells during 
fibrosis, showed a dependence on the fibrotic model used. In the adenine-induced 
nephropathy Cox-2 seems to play some role in the induction of Col1a1 mRNA 
expression. But a deletion of Cox-2 in PDGFR-β+ cells had no effect on the expression 
of fibrotic markers in the UUO model.  
The characterization of markers for Cox-2 expressing cells in the kidney is the basis 
for a targeted deletion in sub-compartments and their functional investigation. While 
Cox-2 expression in medullary interstitial cells is not essential for normal kidney 
development, it is necessary for blood pressure homeostasis during a high salt 
challenge.   
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7 Annex 
7.1 Abbreviations 
°C degree Celsius 
AA arachidonic acid 
AB antibody 
ACE Angiotensin converting enzym 
ANG I Angiotensin I 
AR aldose reductase  
BGT1 sodium and chloride dependent betain/GABA transpoter 1 
bp base pair 
BSA Bovine Serum Albumin 
BW body weight 
CAGG artificial CAG Promotor 
cAMP  cyclic adenosine monophosphate  
CD collecting duct 
CD73 ecto-5'-nucleotidase 
CKD Chronic kidney disease 
Col1a1 Collagen, type I, alpha 1 
Cox-2 Cyclooxygenase 2 
CreERT2 tamoxifen-inducible Cre-ERT2 fusion protein 
cTAL cortical thick ascending limp of the loop of Henle  
Cy Cyanine 
DAPI 4′,6-Diamidin-2-phenylindol 
DNA Deoxyribonucleic acid 
ENAC Epithelial sodium channel 
EPO Erythropoetin 
FoxD1 forkhead box D1  
FSB first strand buffer 5x  
gDNA genomic DNA 
GFR glomerular filtration rate 
h hour 
HEPES  (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) 
HIF hypoxia inducible factor 
HoxB7 homebox protein B7 
HS Horse Serum 
HSP70 heat shock protein 70 
i.p inter peritoneal 
IF Immunofluorescence 
IL interleukin 
ISH In-situ hybridization  
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JGA juxtaglomerular apparatus  
MEF2 myocyte enhancer factor-2 
min minute 
mMol/l million moles per liter 
mOsmol/l million osmoles per liter 
mPGES membrane associated prostaglandin E synthase 
mRNA Messenger ribonucleic acid 
NBF Neutral buffered formalin 
NF nuclear factor  
NFAT Nuclear factor of activated T-cells 
NFκB nuclear factor kappa-light-chain-enhancer of activated B cells specificity 
protein 1 
NG2 Neural/glial antigen 2 
NKCC2 Na+-K+-Cl- cotransporter 
nm nanometer  
NSAID non steroidal anti-inflammatory drug 
PBS Phosphate buffered saline 
PDGF platelet derived growth factor 
PG prostaglandin  
PMSF Phenylmethylsulfonylfluorid 
PTGS prostaglandin endoperoxide synthase 
RNA ribonucleic acid 
RPL32 Ribosomal Protein L32 
rpm revolutions per minute 
RT room temperature  
s second 
Six2 six homebox 2 
SMIT sodium dependent myo-inositol cotransporter  
SM-MHC Smooth Muscle Myosin Heavy Chain 
SP1 specificity protein 1 
SR picro-sirius red staining 
TNC tenascin – C  
TRITC 5(6)-Tetramethylrhodaminisothiocyanat 
TX thromboxane 
UTA1 Urea transporter A1 
UUO unilateral ureter obstruction 
V Volt 
Vhl von-Hippel-Lindau  
wks weeks 
WT wildtype  
MWF rat Munich Wistar Frömter rat 
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